{
  "events": [
    {
      "id": 1639,
      "body": "<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>",
      "type": "meeting",
      "title": "Calendly: Intro to Meetings.bio",
      "sender": null,
      "persons": [
        {
          "emails": [
            "kwalker@porsolt.com"
          ],
          "full_name": "Kendall Walker",
          "last_name": "Walker",
          "first_name": "Kendall",
          "organizations": []
        }
      ],
      "direction": "EventDirection.BIDIRECTIONAL",
      "timestamp": "2024-02-22T22:15:00Z",
      "message_id": null,
      "recipients": null,
      "cc_recipients": null,
      "bcc_recipients": null
    }
  ],
  "offering": null,
  "deal_name": "PORSOLT",
  "prospects": [
    {
      "emails": [
        "kwalker@porsolt.com"
      ],
      "full_name": "Kendall Walker",
      "last_name": "Walker",
      "first_name": "Kendall",
      "organizations": [
        {
          "name": "PORSOLT",
          "domains": [
            "porsolt.com"
          ],
          "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
          "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
        }
      ]
    }
  ],
  "deal_owner_email": "klemen@meetings.bio",
  "primary_prospect": {
    "emails": [
      "kwalker@porsolt.com"
    ],
    "full_name": "Kendall Walker",
    "last_name": "Walker",
    "first_name": "Kendall",
    "organizations": [
      {
        "name": "PORSOLT",
        "domains": [
          "porsolt.com"
        ],
        "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
        "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
      }
    ]
  },
  "deal_owner_full_name": "Klemen Hrovat",
  "deal_owner_last_name": "Hrovat",
  "deal_owner_first_name": "Klemen",
  "deal_owner_customer_name": "Meetings.bio",
  "deal_owner_customer_domain": "meetings.bio",
  "primary_prospect_organization": {
    "name": "PORSOLT",
    "domains": [
      "porsolt.com"
    ],
    "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
    "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
  }
}

{
  "id": 32033,
  "deal": {
    "id": 560,
    "name": "PORSOLT",
    "owner": 2,
    "stage": 4,
    "public_id": "5cf0b743-4b50-4463-9103-a3755838c986",
    "external_id": "17656118199",
    "last_modified_in_crm": null
  },
  "vars": null,
  "state": null,
  "status": "INITIATED",
  "next_task": null,
  "events_hash": null,
  "fingerprint": null,
  "next_task_key": null
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: Below is an email exchange between a seller whose name is Klemen Hrovat and a buyer. You task is to determine into which sales pipeline stage this deal would need to be categorized. The deal is represented by the given communication and accompanying metadata.\n\nThe following pipeline stages are available: LEAD, EXPLORATORY, PROPOSAL, CLOSING, NOT_NOW, CLOSED_WON, CLOSED_LOST.\n\nThe following are the requirements that need to be met in order to categorize the conversation into one of the pipeline stages:\n\n* LEAD:\n\n- No meetings were yet scheduled between the seller and the buyer.\n- There is no indication that the buyer does not want to proceed, there is no indication that it is bad timing.\n- The deal is not yet at the stage when a written proposal is suppose to be or was sent to the buyer.\n- There is no indication that sufficient information about offering was delivered to the buyer so that it is possible to move forward with closing.\n- There is no indication that an agreement has been delivered to the buyer or signed by the buyer.\n\n\n* EXPLORATORY:\n\n- The introductory meeting was already scheduled.\n- There is no indication that the buyer does not want to proceed, there is no indication that it is bad timing.\n- The deal is not yet at the stage when a written proposal is suppose to be or was sent to the buyer.\n- There is no indication that sufficient information about offering was delivered to the buyer so that it is possible to move forward with closing.\n- There is no indication that an agreement has been delivered to the buyer or signed by the buyer.\n\n\n* PROPOSAL:\n\n- There is a clear indication that a written proposal needs to be sent to the buyer (but was not sent yet).\n- There is no indication that the buyer does not want to proceed, there is no indication that it is bad timing.\n- There is no indication that sufficient information about offering was delivered to the buyer so that it is possible to move forward with closing.\n- There is no indication that an agreement has been delivered to the buyer or signed by the buyer.\n\n\n* CLOSING:\n\n- There is a clear indication that a written proposal has been delivered to the buyer, or there is an explicit notion that sufficient information about offering was delivered to the buyer so that it is possible to move forward with closing.\n- There is no indication that the buyer does not want to proceed, there is no indication that it is bad timing.\n- There is no indication that an agreement has been delivered to the buyer or signed by the buyer.\n\n\n* NOT_NOW\n\n- There is an indication from the buyer that the timing is not right to proceed with the deal.\n- There is no indication that the buyer does not want to proceed in general.\n- There is no indication that an agreement has been delivered to the buyer or signed by the buyer.\n\n\n* CLOSED_WON\n\n- There is a clear indication that the agreement was signed by the buyer.\n- IMPORTANT: It needs to be very clear and explicit that the agreement was signed. It is not good enough if the agreement is about to be signed. If the agreement is in the process of being signed but was not signed yet, you should classify the deal into \"CLOSING\".\n\n\n* CLOSED_LOST\n\n- There is a clear indication that the buyer does not want to proceed with deal (as in not being interested).\n- There is no indication that an agreement has been delivered to the buyer or signed by the buyer.\n\n\nTake special care when classifying into CLOSED_WON and CLOSED_LOST categories. The deal is considered CLOSED_LOST if and only if the buyer expressed very explicitly that they do not want to receive any further emails or that they are not interested. The deal is considered CLOSED_WON if and only if it is clear that the agreement was already signed and that the deal has been successfully closed. If you are unsure whether the deal has already been closed or not, rather select one of the non-closed categories.\n\n---\n\nThe following conversation needs to be examined and categorized:\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 08:12:01.556375."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "category",
          "explanation"
        ],
        "properties": {
          "category": {
            "enum": [
              "LEAD",
              "EXPLORATORY",
              "PROPOSAL",
              "CLOSING",
              "NOT_NOW",
              "CLOSED_WON",
              "CLOSED_LOST"
            ],
            "type": "string",
            "title": "Category"
          },
          "explanation": {
            "type": "string",
            "title": "Explanation"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BeOfdBERPJ46qv4aXzF8lwmbkpw8",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1717,
    "prompt_tokens": 1590,
    "completion_tokens": 127
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"category\":\"EXPLORATORY\",\"explanation\":\"The conversation indicates that an introductory meeting was already scheduled, as evidenced by the meeting invitation for an 'Intro to Meetings.bio' with a specified time and location. There is no indication that the buyer does not want to proceed, nor is there any indication that it is bad timing for them. Additionally, there is no mention of a written proposal being sent or an agreement being delivered or signed by the buyer. Therefore, this deal falls into the 'EXPLORATORY' stage, where the introductory meeting has been scheduled but no further steps towards closing the deal have been taken.\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712563921,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: Below is an email exchange between a seller whose name is Klemen Hrovat and a buyer. You task is to determine whether the given conversation conforms to the given requirements. \n\nYou should categorize it into \"YES\" if the deal indeed fulfills the requirements, or into \"NO\" if it does not.\n\nThese are the requirements that need to be fulfilled:\n\n* LEAD:\n\n- No meetings were yet scheduled between the seller and the buyer.\n- There is no indication that the buyer does not want to proceed, there is no indication that it is bad timing.\n- The deal is not yet at the stage when a written proposal is suppose to be or was sent to the buyer.\n- There is no indication that sufficient information about offering was delivered to the buyer so that it is possible to move forward with closing.\n- There is no indication that an agreement has been delivered to the buyer or signed by the buyer.\n\n\nPlease examine the conversation carefully and categorize the deal either into \"YES\" (as in \"yes, the deal fulfills the given requirements\"), or \"NO\" (as in \"no, this deal does not fulfill the given requirements\").\n\nThe following conversation needs to be examined and categorized:\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 08:12:07.058067."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "category",
          "explanation"
        ],
        "properties": {
          "category": {
            "enum": [
              "YES",
              "NO"
            ],
            "type": "string",
            "title": "Category"
          },
          "explanation": {
            "type": "string",
            "title": "Explanation"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BeOlJj4zeoPmXe0N4Kh9Q3AB6XyR",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1053,
    "prompt_tokens": 979,
    "completion_tokens": 74
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"category\":\"NO\",\"explanation\":\"The conversation indicates that a meeting was scheduled between the seller and the buyer, as evidenced by the event type being a meeting and the provision of a Zoom link for the meeting. This directly contradicts the requirement that no meetings were yet scheduled between the seller and the buyer. Therefore, the deal does not fulfill the given requirements.\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712563927,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: Below is an email exchange between a seller whose name is Klemen Hrovat and a buyer. You task is to determine whether the given conversation conforms to the given requirements. \n\nYou should categorize it into \"YES\" if the deal indeed fulfills the requirements, or into \"NO\" if it does not.\n\nThese are the requirements that need to be fulfilled:\n\n* EXPLORATORY:\n\n- The introductory meeting was already scheduled.\n- There is no indication that the buyer does not want to proceed, there is no indication that it is bad timing.\n- The deal is not yet at the stage when a written proposal is suppose to be or was sent to the buyer.\n- There is no indication that sufficient information about offering was delivered to the buyer so that it is possible to move forward with closing.\n- There is no indication that an agreement has been delivered to the buyer or signed by the buyer.\n\n\nPlease examine the conversation carefully and categorize the deal either into \"YES\" (as in \"yes, the deal fulfills the given requirements\"), or \"NO\" (as in \"no, this deal does not fulfill the given requirements\").\n\nThe following conversation needs to be examined and categorized:\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 08:12:10.397424."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "category",
          "explanation"
        ],
        "properties": {
          "category": {
            "enum": [
              "YES",
              "NO"
            ],
            "type": "string",
            "title": "Category"
          },
          "explanation": {
            "type": "string",
            "title": "Explanation"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BeOosRcMvpeiWfj5sEnWwu20iySX",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1118,
    "prompt_tokens": 976,
    "completion_tokens": 142
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"category\":\"YES\",\"explanation\":\"The conversation indicates that an introductory meeting was already scheduled for 2024-02-22, fulfilling the requirement of having an introductory meeting scheduled. There is no indication in the conversation that the buyer, PORSOLT, does not want to proceed or that it is a bad timing for them. Additionally, there is no mention of a written proposal being sent or supposed to be sent, nor is there any indication that sufficient information about the offering was delivered to the buyer to move forward with closing. Finally, there is no mention of an agreement being delivered to or signed by the buyer. Therefore, the deal fulfills all the given requirements for the exploratory stage.\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712563930,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: Below is an email exchange between a seller whose name is Klemen Hrovat and a buyer. You task is to determine whether the given conversation conforms to the given requirements. \n\nYou should categorize it into \"YES\" if the deal indeed fulfills the requirements, or into \"NO\" if it does not.\n\nThese are the requirements that need to be fulfilled:\n\n* PROPOSAL:\n\n- There is a clear indication that a written proposal needs to be sent to the buyer (but was not sent yet).\n- There is no indication that the buyer does not want to proceed, there is no indication that it is bad timing.\n- There is no indication that sufficient information about offering was delivered to the buyer so that it is possible to move forward with closing.\n- There is no indication that an agreement has been delivered to the buyer or signed by the buyer.\n\n\nPlease examine the conversation carefully and categorize the deal either into \"YES\" (as in \"yes, the deal fulfills the given requirements\"), or \"NO\" (as in \"no, this deal does not fulfill the given requirements\").\n\nThe following conversation needs to be examined and categorized:\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 08:12:18.434583."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "category",
          "explanation"
        ],
        "properties": {
          "category": {
            "enum": [
              "YES",
              "NO"
            ],
            "type": "string",
            "title": "Category"
          },
          "explanation": {
            "type": "string",
            "title": "Explanation"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BeOwDCe2uGHOLGGbaV0YtgEQAWv6",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1101,
    "prompt_tokens": 967,
    "completion_tokens": 134
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"category\":\"YES\",\"explanation\":\"The conversation indicates a meeting setup via Calendly for an introduction to Meetings.bio, with no prior proposal sent. The body of the message requests information to help prepare for the meeting, suggesting that sufficient information about the offering has not yet been delivered to the buyer, which aligns with the requirement that there should be no indication that sufficient information was delivered to move forward with closing. Additionally, there is no indication that an agreement has been delivered or signed by the buyer, nor is there any indication that the buyer does not want to proceed or that it is a bad timing. Therefore, the deal fulfills the given requirements.\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712563938,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: Below is an email exchange between a seller whose name is Klemen Hrovat and a buyer. You task is to determine whether the given conversation conforms to the given requirements. \n\nYou should categorize it into \"YES\" if the deal indeed fulfills the requirements, or into \"NO\" if it does not.\n\nThese are the requirements that need to be fulfilled:\n\n* CLOSING:\n\n- There is a clear indication that a written proposal has been delivered to the buyer, or there is an explicit notion that sufficient information about offering was delivered to the buyer so that it is possible to move forward with closing.\n- There is no indication that the buyer does not want to proceed, there is no indication that it is bad timing.\n- There is no indication that an agreement has been delivered to the buyer or signed by the buyer.\n\n\nPlease examine the conversation carefully and categorize the deal either into \"YES\" (as in \"yes, the deal fulfills the given requirements\"), or \"NO\" (as in \"no, this deal does not fulfill the given requirements\").\n\nThe following conversation needs to be examined and categorized:'\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 08:12:24.579713."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "category",
          "explanation"
        ],
        "properties": {
          "category": {
            "enum": [
              "YES",
              "NO"
            ],
            "type": "string",
            "title": "Category"
          },
          "explanation": {
            "type": "string",
            "title": "Explanation"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BeP3iLYu4RxFUhHZNrMGdGooSzr0",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1105,
    "prompt_tokens": 962,
    "completion_tokens": 143
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"category\":\"NO\",\"explanation\":\"The provided text outlines the setup for a meeting between the deal owner (Klemen Hrovat from Meetings.bio) and the prospect (Kendall Walker from PORSOLT), with the purpose of discussing PORSOLT's needs and how Meetings.bio might assist them. However, there is no clear indication that a written proposal has been delivered to the buyer, nor is there an explicit notion that sufficient information about the offering was delivered to the buyer to move forward with closing. The text primarily focuses on the meeting setup and PORSOLT's background and needs, without mentioning any proposal or agreement being delivered or signed. Therefore, the deal does not fulfill the given requirements.\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712563945,
  "system_fingerprint": "fp_54b778f7c8"
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: Below is an email exchange between a seller whose name is Klemen Hrovat and a buyer. You task is to determine whether the given conversation conforms to the given requirements. \n\nYou should categorize it into \"YES\" if the deal indeed fulfills the requirements, or into \"NO\" if it does not.\n\nThese are the requirements that need to be fulfilled:\n\n* NOT_NOW\n\n- There is an indication from the buyer that the timing is not right to proceed with the deal.\n- There is no indication that the buyer does not want to proceed in general.\n- There is no indication that an agreement has been delivered to the buyer or signed by the buyer.\n\n\nPlease examine the conversation carefully and categorize the deal either into \"YES\" (as in \"yes, the deal fulfills the given requirements\"), or \"NO\" (as in \"no, this deal does not fulfill the given requirements\").\n\nThe following conversation needs to be examined and categorized:\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 08:12:31.021369."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "category",
          "explanation"
        ],
        "properties": {
          "category": {
            "enum": [
              "YES",
              "NO"
            ],
            "type": "string",
            "title": "Category"
          },
          "explanation": {
            "type": "string",
            "title": "Explanation"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BeP9oJ405mpAtulPZtqzAdAhMupy",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1072,
    "prompt_tokens": 928,
    "completion_tokens": 144
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"category\":\"NO\",\"explanation\":\"The provided text is a description of a scheduled meeting between Meetings.bio and PORSOLT, focusing on an introduction to Meetings.bio. There is no indication from the buyer (PORSOLT) that the timing is not right to proceed with the deal. Additionally, there is no communication from the buyer expressing a desire to delay or any concerns about the timing. The text primarily outlines the context for the meeting, including the location, time zone, and a brief about PORSOLT's business and challenges. Therefore, it does not fulfill the 'NOT_NOW' requirements as there is no explicit or implied message from the buyer regarding the timing not being right to proceed with the deal.\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712563951,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: Below is an email exchange between a seller whose name is Klemen Hrovat and a buyer. You task is to determine whether the given conversation conforms to the given requirements. \n\nYou should categorize it into \"YES\" if the deal indeed fulfills the requirements, or into \"NO\" if it does not.\n\nThese are the requirements that need to be fulfilled:\n\n* CLOSED_WON\n\n- There is a clear indication that the agreement was signed by the buyer.\n- IMPORTANT: It needs to be very clear and explicit that the agreement was signed. It is not good enough if the agreement is about to be signed. If the agreement is in the process of being signed but was not signed yet, you should classify the deal into \"CLOSING\".\n\n\nPlease examine the conversation carefully and categorize the deal either into \"YES\" (as in \"yes, the deal fulfills the given requirements\"), or \"NO\" (as in \"no, this deal does not fulfill the given requirements\").\n\nThe following conversation needs to be examined and categorized:\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 08:12:38.604488."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "category",
          "explanation"
        ],
        "properties": {
          "category": {
            "enum": [
              "YES",
              "NO"
            ],
            "type": "string",
            "title": "Category"
          },
          "explanation": {
            "type": "string",
            "title": "Explanation"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BePGbWm5QmSCKG88p8hAp6W3fLb7",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1035,
    "prompt_tokens": 947,
    "completion_tokens": 88
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"category\":\"NO\",\"explanation\":\"The provided text is an invitation to a meeting and does not contain any information about an agreement being signed or any indication that a deal has been closed. It merely outlines the purpose of the meeting and provides background information on Porsolt, the prospect company. There is no explicit or clear indication of an agreement being signed, thus it does not fulfill the requirements for being categorized as CLOSED_WON.\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712563958,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: Below is an email exchange between a seller whose name is Klemen Hrovat and a buyer. You task is to determine whether the given conversation conforms to the given requirements. \n\nYou should categorize it into \"YES\" if the deal indeed fulfills the requirements, or into \"NO\" if it does not.\n\nThese are the requirements that need to be fulfilled:\n\n* CLOSED_LOST\n\n- There is a clear indication that the buyer does not want to proceed with deal (as in not being interested).\n- There is no indication that an agreement has been delivered to the buyer or signed by the buyer.\n\n\nPlease examine the conversation carefully and categorize the deal either into \"YES\" (as in \"yes, the deal fulfills the given requirements\"), or \"NO\" (as in \"no, this deal does not fulfill the given requirements\").\n\nThe following conversation needs to be examined and categorized:\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 08:12:42.268339."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "category",
          "explanation"
        ],
        "properties": {
          "category": {
            "enum": [
              "YES",
              "NO"
            ],
            "type": "string",
            "title": "Category"
          },
          "explanation": {
            "type": "string",
            "title": "Explanation"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BePK2WhfjyXT1aO9dCxxYyNW3Y9N",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1017,
    "prompt_tokens": 916,
    "completion_tokens": 101
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"category\":\"NO\",\"explanation\":\"The provided text does not contain any clear indication that the buyer does not want to proceed with the deal. It is a description of a scheduled meeting between the deal owner and the prospect, focusing on the prospect's business and needs. There is no mention of an agreement being delivered or signed, but there is also no indication of disinterest or refusal from the buyer's side. Therefore, it cannot be concluded that the deal fulfills the CLOSED_LOST requirements.\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712563962,
  "system_fingerprint": "fp_239398b68a"
}

{
  "events": [
    {
      "id": 1639,
      "body": "<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>",
      "type": "meeting",
      "title": "Calendly: Intro to Meetings.bio",
      "sender": null,
      "persons": [
        {
          "emails": [
            "kwalker@porsolt.com"
          ],
          "full_name": "Kendall Walker",
          "last_name": "Walker",
          "first_name": "Kendall",
          "organizations": []
        }
      ],
      "direction": "EventDirection.BIDIRECTIONAL",
      "timestamp": "2024-02-22T22:15:00Z",
      "message_id": null,
      "recipients": null,
      "cc_recipients": null,
      "bcc_recipients": null
    }
  ],
  "offering": null,
  "deal_name": "PORSOLT",
  "prospects": [
    {
      "emails": [
        "kwalker@porsolt.com"
      ],
      "full_name": "Kendall Walker",
      "last_name": "Walker",
      "first_name": "Kendall",
      "organizations": [
        {
          "name": "PORSOLT",
          "domains": [
            "porsolt.com"
          ],
          "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
          "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
        }
      ]
    }
  ],
  "deal_owner_email": "klemen@meetings.bio",
  "primary_prospect": {
    "emails": [
      "kwalker@porsolt.com"
    ],
    "full_name": "Kendall Walker",
    "last_name": "Walker",
    "first_name": "Kendall",
    "organizations": [
      {
        "name": "PORSOLT",
        "domains": [
          "porsolt.com"
        ],
        "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
        "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
      }
    ]
  },
  "deal_owner_full_name": "Klemen Hrovat",
  "deal_owner_last_name": "Hrovat",
  "deal_owner_first_name": "Klemen",
  "deal_owner_customer_name": "Meetings.bio",
  "deal_owner_customer_domain": "meetings.bio",
  "primary_prospect_organization": {
    "name": "PORSOLT",
    "domains": [
      "porsolt.com"
    ],
    "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
    "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
  }
}

{
  "id": 32033,
  "deal": {
    "id": 560,
    "name": "PORSOLT",
    "owner": 2,
    "stage": 4,
    "public_id": "5cf0b743-4b50-4463-9103-a3755838c986",
    "external_id": "17656118199",
    "last_modified_in_crm": null
  },
  "vars": {
    "pipeline_stage": "EXPLORATORY",
    "pipeline_stage_binary": [
      "EXPLORATORY",
      "PROPOSAL"
    ]
  },
  "state": "REPLY_OR_REMINDER",
  "status": "IN_PROGRESS",
  "next_task": null,
  "events_hash": "bd5f9613eb2b86326a727cc7128859be33783afb",
  "fingerprint": {
    "events": "bd5f9613eb2b86326a727cc7128859be33783afb",
    "offering": "2ef87dc4b9c9e813e0e0433d7547e6b7541d95f5",
    "prospect": "13d1d0befdfe27f64dcf8703ce7bc272ff215882",
    "deal_owner": "ec6bf4d5effdd54ce2a619ab6b933981f503e715"
  },
  "next_task_key": null
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: Below is an email exchange between a seller whose name is Klemen Hrovat and a buyer. You task is to determine whether the next seller's action should be an immediate REPLY (category \"REPLY\") or whether the seller should schedule a follow-up REMINDER (category \"REMINDER\").\n\nNormally, if the buyer wrote the last email in the correspondence, the seller should REPLY to that, if nothing else, with a courteous one-liner. The only exception is when the buyer has sent the last email but that email does not carry any information goal or intent; it is merely a courteous one-liner saying \"thank you\" or something similar.\n\nAlso, if the seller wrote the last email, the seller should schedule a kind REMINDER. The only exception is when seller is not expecting any response from the buyer (because, for example, the conversation is undoubtedly concluded).\n\nIf there is an indication that the last event was a meeting or a similar interation in which both the buyer and the seller were able to discuss the deal, then the correct category is \"REPLY\" (because the seller should send a recap email and give information on next steps).\n\nBased on these instructions, classify the correspondence into one of the two categories:\n\n* REPLY - The seller should send a reply as the buyer is awaiting a response. This is also the case if the last event was a meeting or a similar interaction in which both the buyer and the seller were able to discuss the deal.\n* REMINDER - The seller is in the process of waiting for the buyer's message. The seller should thus schedule to send a kind reminder.\n\nThe following is the correspondence between the buyer and the seller. The last event in this list is the latest one. The latest event is probably the most important one for making a decision.\n\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 08:22:24.615845."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "category",
          "explanation"
        ],
        "properties": {
          "category": {
            "enum": [
              "REPLY",
              "REMINDER"
            ],
            "type": "string",
            "title": "Category"
          },
          "explanation": {
            "type": "string",
            "title": "Explanation"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BeYign8TXNWY491QmDPrwEWSq6pm",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1185,
    "prompt_tokens": 1103,
    "completion_tokens": 82
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"category\":\"REPLY\",\"explanation\":\"The last event in the correspondence is a meeting, indicating that both the buyer and the seller were able to discuss the deal. Following such a meeting, it is customary and expected for the seller to send a recap email and provide information on the next steps. Therefore, the correct action for the seller, Klemen Hrovat, is to send a reply.\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712564544,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "events": [
    {
      "id": 1639,
      "body": "<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>",
      "type": "meeting",
      "title": "Calendly: Intro to Meetings.bio",
      "sender": null,
      "persons": [
        {
          "emails": [
            "kwalker@porsolt.com"
          ],
          "full_name": "Kendall Walker",
          "last_name": "Walker",
          "first_name": "Kendall",
          "organizations": []
        }
      ],
      "direction": "EventDirection.BIDIRECTIONAL",
      "timestamp": "2024-02-22T22:15:00Z",
      "message_id": null,
      "recipients": null,
      "cc_recipients": null,
      "bcc_recipients": null
    }
  ],
  "offering": null,
  "deal_name": "PORSOLT",
  "prospects": [
    {
      "emails": [
        "kwalker@porsolt.com"
      ],
      "full_name": "Kendall Walker",
      "last_name": "Walker",
      "first_name": "Kendall",
      "organizations": [
        {
          "name": "PORSOLT",
          "domains": [
            "porsolt.com"
          ],
          "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
          "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
        }
      ]
    }
  ],
  "deal_owner_email": "klemen@meetings.bio",
  "primary_prospect": {
    "emails": [
      "kwalker@porsolt.com"
    ],
    "full_name": "Kendall Walker",
    "last_name": "Walker",
    "first_name": "Kendall",
    "organizations": [
      {
        "name": "PORSOLT",
        "domains": [
          "porsolt.com"
        ],
        "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
        "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
      }
    ]
  },
  "deal_owner_full_name": "Klemen Hrovat",
  "deal_owner_last_name": "Hrovat",
  "deal_owner_first_name": "Klemen",
  "deal_owner_customer_name": "Meetings.bio",
  "deal_owner_customer_domain": "meetings.bio",
  "primary_prospect_organization": {
    "name": "PORSOLT",
    "domains": [
      "porsolt.com"
    ],
    "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
    "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
  }
}

{
  "id": 32033,
  "deal": {
    "id": 560,
    "name": "PORSOLT",
    "owner": 2,
    "stage": 4,
    "public_id": "5cf0b743-4b50-4463-9103-a3755838c986",
    "external_id": "17656118199",
    "last_modified_in_crm": null
  },
  "vars": {
    "pipeline_stage": "EXPLORATORY",
    "pipeline_stage_binary": [
      "EXPLORATORY",
      "PROPOSAL"
    ]
  },
  "state": "DETERMINE_PROSPECT_INTENT",
  "status": "IN_PROGRESS",
  "next_task": null,
  "events_hash": "bd5f9613eb2b86326a727cc7128859be33783afb",
  "fingerprint": {
    "events": "bd5f9613eb2b86326a727cc7128859be33783afb",
    "offering": "2ef87dc4b9c9e813e0e0433d7547e6b7541d95f5",
    "prospect": "13d1d0befdfe27f64dcf8703ce7bc272ff215882",
    "deal_owner": "ec6bf4d5effdd54ce2a619ab6b933981f503e715"
  },
  "next_task_key": null
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: Below is an email exchange between a seller whose name is Klemen Hrovat and a buyer. You task is to determine the buyer's intent or information goal so that the seller can respond correctly. Therefore, examine the correspondence between the buyer and the seller and categorize it into one of the given categories.\n\nClassify the correspondence into one of the following categories:\n* PRODUCT_INFO - The buyer requests more information about the product or service.\n* PRICING_INFO - The buyer requests more information about pricing plans or costs related to the products and/or services.\n* NEXT_STEPS - The buyer is asking how to proceed or explaining what they need to do next. Even if this request is implicit, try to determine whether the buyer and the seller are at the point where they should discuss next steps.\n* INVOLVE_OTHER_PEOPLE - The buyer needs to involve or consult with other people before the discussion can continue.\n* OTHER_OR_MIXED - The buyer's information goal or intent is none of the above or more than one of the above.\n\nThe following is the correspondence between the buyer and the seller. The last event in this list is the latest one. The latest event is probably the most important one for making a decision.\n\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 08:33:26.647661."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "category",
          "explanation"
        ],
        "properties": {
          "category": {
            "enum": [
              "PRODUCT_INFO",
              "PRICING_INFO",
              "NEXT_STEPS",
              "OTHER"
            ],
            "type": "string",
            "title": "Category"
          },
          "explanation": {
            "type": "string",
            "title": "Explanation"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BejOiOR8ySMaWFUq5wUSFzTb2PoI",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1099,
    "prompt_tokens": 996,
    "completion_tokens": 103
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"category\":\"NEXT_STEPS\",\"explanation\":\"The correspondence is about a scheduled meeting between the seller (Meetings.bio) and the buyer (PORSOLT). The buyer has provided information about their company, PORSOLT, and mentioned their current challenges with outreach strategy and conversion in the US. This context suggests that the meeting's purpose is to discuss how Meetings.bio can assist PORSOLT with their outreach and conversion issues, indicating that they are at the stage of discussing next steps to address these challenges.\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712565206,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "events": [
    {
      "id": 1639,
      "body": "<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>",
      "type": "meeting",
      "title": "Calendly: Intro to Meetings.bio",
      "sender": null,
      "persons": [
        {
          "emails": [
            "kwalker@porsolt.com"
          ],
          "full_name": "Kendall Walker",
          "last_name": "Walker",
          "first_name": "Kendall",
          "organizations": []
        }
      ],
      "direction": "EventDirection.BIDIRECTIONAL",
      "timestamp": "2024-02-22T22:15:00Z",
      "message_id": null,
      "recipients": null,
      "cc_recipients": null,
      "bcc_recipients": null
    }
  ],
  "offering": null,
  "deal_name": "PORSOLT",
  "prospects": [
    {
      "emails": [
        "kwalker@porsolt.com"
      ],
      "full_name": "Kendall Walker",
      "last_name": "Walker",
      "first_name": "Kendall",
      "organizations": [
        {
          "name": "PORSOLT",
          "domains": [
            "porsolt.com"
          ],
          "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
          "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
        }
      ]
    }
  ],
  "deal_owner_email": "klemen@meetings.bio",
  "primary_prospect": {
    "emails": [
      "kwalker@porsolt.com"
    ],
    "full_name": "Kendall Walker",
    "last_name": "Walker",
    "first_name": "Kendall",
    "organizations": [
      {
        "name": "PORSOLT",
        "domains": [
          "porsolt.com"
        ],
        "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
        "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
      }
    ]
  },
  "deal_owner_full_name": "Klemen Hrovat",
  "deal_owner_last_name": "Hrovat",
  "deal_owner_first_name": "Klemen",
  "deal_owner_customer_name": "Meetings.bio",
  "deal_owner_customer_domain": "meetings.bio",
  "primary_prospect_organization": {
    "name": "PORSOLT",
    "domains": [
      "porsolt.com"
    ],
    "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
    "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
  }
}

{
  "id": 32033,
  "deal": {
    "id": 560,
    "name": "PORSOLT",
    "owner": 2,
    "stage": 4,
    "public_id": "5cf0b743-4b50-4463-9103-a3755838c986",
    "external_id": "17656118199",
    "last_modified_in_crm": null
  },
  "vars": {
    "pipeline_stage": "EXPLORATORY",
    "pipeline_stage_binary": [
      "EXPLORATORY",
      "PROPOSAL"
    ]
  },
  "state": "DETERMINE_PROSPECT_INTENT",
  "status": "IN_PROGRESS",
  "next_task": null,
  "events_hash": "bd5f9613eb2b86326a727cc7128859be33783afb",
  "fingerprint": {
    "events": "bd5f9613eb2b86326a727cc7128859be33783afb",
    "offering": "2ef87dc4b9c9e813e0e0433d7547e6b7541d95f5",
    "prospect": "13d1d0befdfe27f64dcf8703ce7bc272ff215882",
    "deal_owner": "ec6bf4d5effdd54ce2a619ab6b933981f503e715"
  },
  "next_task_key": null
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: You are a professional sales person. Your name is Klemen Hrovat. Your task is to respond to the prospect's last email. Make sure to read carefully what the prospect's information goal or intent is, and respond to the best of your knowledge and ability.\n\nThe prospect's intent might be, but is not limited to, one of the following:\n* Postpone the discussion to a later time in the future.\n* Acquire more information about the product or services.\n* Acquire information about pricing.\n* Understand how to proceed (next steps).\n* Other.\n\nDo your best to follow these copywriting rules:\n- NEVER use any variation of sentences starting with \"I hope this email finds you\" or \"I hope this message finds you\"\n- Be concise and to the point, keep emails below 200 words, if possible\n- Write with assertiveness showing sender's confidence, competence, resilience\n- Include a soft yet clear call-to-action that encourages a response\n- Be unique and do not repeat phrases or sentences from your previous messages\n- Align with recipients' priorities, role, expertise, industry\n- Connect on an emotional level, address buyer's pain points\n- Avoid being \"too salesy\"\n\n\nThe following is the correspondence between the buyer and the seller. The last event in this list is the latest one. The latest event is probably the most important one for making a decision.\n\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 08:33:38.233798."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "content_draft",
          "content_recipients",
          "content_subject"
        ],
        "properties": {
          "content_draft": {
            "type": "string",
            "title": "Content draft"
          },
          "content_subject": {
            "type": "string",
            "title": "Content subject"
          },
          "content_recipients": {
            "type": "array",
            "items": {
              "type": "string"
            },
            "title": "Content recipients"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BejaVPLgC1Yzeks9vfjkckQFOduZ",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1269,
    "prompt_tokens": 1027,
    "completion_tokens": 242
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"content_draft\":\"Dear Kendall,\\n\\nThank you for sharing the details about Porsolt and your current challenges. It's clear that enhancing visibility and improving conversion rates in the US market are key priorities for you. At Meetings.bio, we specialize in creating tailored outreach strategies that not only increase visibility but also significantly boost conversion rates, especially for companies in the biotech and pharma sectors.\\n\\nGiven your focus on expanding beyond CNS capabilities, I believe our services could be particularly beneficial. We can help you target the right audience with the right message, ensuring your outreach efforts are more effective and yield better results.\\n\\nI would love to discuss how we can specifically tailor our services to meet Porsolt's unique needs and objectives. Could we schedule a follow-up call next week to dive deeper into this? Please let me know a time that works best for you, or feel free to book a slot directly through my Calendly link.\\n\\nLooking forward to helping Porsolt achieve its US market goals.\\n\\nBest regards,\\nKlemen Hrovat\",\"content_recipients\":[\"Kendall Walker\"],\"content_subject\":\"Maximizing Your US Market Presence with Tailored Outreach\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712565218,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "events": [
    {
      "id": 1639,
      "body": "<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>",
      "type": "meeting",
      "title": "Calendly: Intro to Meetings.bio",
      "sender": null,
      "persons": [
        {
          "emails": [
            "kwalker@porsolt.com"
          ],
          "full_name": "Kendall Walker",
          "last_name": "Walker",
          "first_name": "Kendall",
          "organizations": []
        }
      ],
      "direction": "EventDirection.BIDIRECTIONAL",
      "timestamp": "2024-02-22T22:15:00Z",
      "message_id": null,
      "recipients": null,
      "cc_recipients": null,
      "bcc_recipients": null
    }
  ],
  "offering": null,
  "deal_name": "PORSOLT",
  "prospects": [
    {
      "emails": [
        "kwalker@porsolt.com"
      ],
      "full_name": "Kendall Walker",
      "last_name": "Walker",
      "first_name": "Kendall",
      "organizations": [
        {
          "name": "PORSOLT",
          "domains": [
            "porsolt.com"
          ],
          "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
          "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
        }
      ]
    }
  ],
  "deal_owner_email": "klemen@meetings.bio",
  "primary_prospect": {
    "emails": [
      "kwalker@porsolt.com"
    ],
    "full_name": "Kendall Walker",
    "last_name": "Walker",
    "first_name": "Kendall",
    "organizations": [
      {
        "name": "PORSOLT",
        "domains": [
          "porsolt.com"
        ],
        "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
        "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
      }
    ]
  },
  "deal_owner_full_name": "Klemen Hrovat",
  "deal_owner_last_name": "Hrovat",
  "deal_owner_first_name": "Klemen",
  "deal_owner_customer_name": "Meetings.bio",
  "deal_owner_customer_domain": "meetings.bio",
  "primary_prospect_organization": {
    "name": "PORSOLT",
    "domains": [
      "porsolt.com"
    ],
    "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
    "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
  }
}

{
  "id": 32033,
  "deal": {
    "id": 560,
    "name": "PORSOLT",
    "owner": 2,
    "stage": 4,
    "public_id": "5cf0b743-4b50-4463-9103-a3755838c986",
    "external_id": "17656118199",
    "last_modified_in_crm": null
  },
  "vars": {
    "pipeline_stage": "EXPLORATORY",
    "pipeline_stage_binary": [
      "EXPLORATORY",
      "PROPOSAL"
    ]
  },
  "state": "CREATE_TASK_FOR_EMAIL_RESPONSE",
  "status": "IN_PROGRESS",
  "next_task": 817,
  "events_hash": "bd5f9613eb2b86326a727cc7128859be33783afb",
  "fingerprint": {
    "events": "bd5f9613eb2b86326a727cc7128859be33783afb",
    "offering": "2ef87dc4b9c9e813e0e0433d7547e6b7541d95f5",
    "prospect": "13d1d0befdfe27f64dcf8703ce7bc272ff215882",
    "deal_owner": "ec6bf4d5effdd54ce2a619ab6b933981f503e715"
  },
  "next_task_key": null
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: You are a professional sales person. Your name is Klemen Hrovat. Your task is to respond to the prospect's last email. Make sure to read carefully what the prospect's information goal or intent is, and respond to the best of your knowledge and ability.\n\nThe prospect's intent might be, but is not limited to, one of the following:\n* Postpone the discussion to a later time in the future.\n* Acquire more information about the product or services.\n* Acquire information about pricing.\n* Understand how to proceed (next steps).\n* Other.\n\nDo your best to follow these copywriting rules:\n- NEVER use any variation of sentences starting with \"I hope this email finds you\" or \"I hope this message finds you\"\n- Be concise and to the point, keep emails below 200 words, if possible\n- Write with assertiveness showing sender's confidence, competence, resilience\n- Include a soft yet clear call-to-action that encourages a response\n- Be unique and do not repeat phrases or sentences from your previous messages\n- Align with recipients' priorities, role, expertise, industry\n- Connect on an emotional level, address buyer's pain points\n- Avoid being \"too salesy\"\n\n\nThe following is the correspondence between the buyer and the seller. The last event in this list is the latest one. The latest event is probably the most important one for making a decision.\n\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 09:32:24.308404."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "content_draft",
          "content_recipients",
          "content_subject"
        ],
        "properties": {
          "content_draft": {
            "type": "string",
            "title": "Content draft"
          },
          "content_subject": {
            "type": "string",
            "title": "Content subject"
          },
          "content_recipients": {
            "type": "array",
            "items": {
              "type": "string"
            },
            "title": "Content recipients"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BfeSeegaStYYWZL2k2ZLrCFp2PNW",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1274,
    "prompt_tokens": 1027,
    "completion_tokens": 247
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"content_draft\":\"Dear Kendall,\\n\\nThank you for sharing the details about Porsolt and your current challenges. It's clear that enhancing visibility and improving conversion rates in the US market are key priorities for you. At Meetings.bio, we specialize in creating tailored outreach strategies that not only increase visibility but also significantly boost conversion rates, especially for companies in the biotech and pharmaceutical sectors.\\n\\nGiven your focus on expanding beyond CNS capabilities, I believe our services could be particularly beneficial. We can help you target the right audience with the right message, ensuring your outreach efforts are more effective and yield better results.\\n\\nI would love to discuss how we can tailor our services to meet Porsolt's specific needs and objectives. Could we schedule a follow-up call next week to explore this further? Please let me know a time that works best for you, or feel free to book a slot directly through my Calendly link.\\n\\nLooking forward to the opportunity to support Porsolt's growth in the US market.\\n\\nBest regards,\\nKlemen Hrovat\",\"content_recipients\":[\"Kendall Walker\"],\"content_subject\":\"Maximizing Your US Market Presence: Tailored Strategies for Porsolt\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712568744,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "events": [
    {
      "id": 1639,
      "body": "<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>",
      "type": "meeting",
      "title": "Calendly: Intro to Meetings.bio",
      "sender": null,
      "persons": [
        {
          "emails": [
            "kwalker@porsolt.com"
          ],
          "full_name": "Kendall Walker",
          "last_name": "Walker",
          "first_name": "Kendall",
          "organizations": []
        }
      ],
      "direction": "EventDirection.BIDIRECTIONAL",
      "timestamp": "2024-02-22T22:15:00Z",
      "message_id": null,
      "recipients": null,
      "cc_recipients": null,
      "bcc_recipients": null
    }
  ],
  "offering": null,
  "deal_name": "PORSOLT",
  "prospects": [
    {
      "emails": [
        "kwalker@porsolt.com"
      ],
      "full_name": "Kendall Walker",
      "last_name": "Walker",
      "first_name": "Kendall",
      "organizations": [
        {
          "name": "PORSOLT",
          "domains": [
            "porsolt.com"
          ],
          "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
          "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
        }
      ]
    }
  ],
  "deal_owner_email": "klemen@meetings.bio",
  "primary_prospect": {
    "emails": [
      "kwalker@porsolt.com"
    ],
    "full_name": "Kendall Walker",
    "last_name": "Walker",
    "first_name": "Kendall",
    "organizations": [
      {
        "name": "PORSOLT",
        "domains": [
          "porsolt.com"
        ],
        "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
        "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
      }
    ]
  },
  "deal_owner_full_name": "Klemen Hrovat",
  "deal_owner_last_name": "Hrovat",
  "deal_owner_first_name": "Klemen",
  "deal_owner_customer_name": "Meetings.bio",
  "deal_owner_customer_domain": "meetings.bio",
  "primary_prospect_organization": {
    "name": "PORSOLT",
    "domains": [
      "porsolt.com"
    ],
    "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
    "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
  }
}

{
  "id": 32033,
  "deal": {
    "id": 560,
    "name": "PORSOLT",
    "owner": 2,
    "stage": 4,
    "public_id": "5cf0b743-4b50-4463-9103-a3755838c986",
    "external_id": "17656118199",
    "last_modified_in_crm": null
  },
  "vars": {
    "pipeline_stage": "EXPLORATORY",
    "pipeline_stage_binary": [
      "EXPLORATORY",
      "PROPOSAL"
    ]
  },
  "state": "CREATE_TASK_FOR_EMAIL_RESPONSE",
  "status": "IN_PROGRESS",
  "next_task": 835,
  "events_hash": "bd5f9613eb2b86326a727cc7128859be33783afb",
  "fingerprint": {
    "events": "bd5f9613eb2b86326a727cc7128859be33783afb",
    "offering": "2ef87dc4b9c9e813e0e0433d7547e6b7541d95f5",
    "prospect": "13d1d0befdfe27f64dcf8703ce7bc272ff215882",
    "deal_owner": "ec6bf4d5effdd54ce2a619ab6b933981f503e715"
  },
  "next_task_key": null
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: You are a professional sales person. Your name is Klemen Hrovat. Your task is to respond to the prospect's last email. Make sure to read carefully what the prospect's information goal or intent is, and respond to the best of your knowledge and ability.\n\nThe prospect's intent might be, but is not limited to, one of the following:\n* Postpone the discussion to a later time in the future.\n* Acquire more information about the product or services.\n* Acquire information about pricing.\n* Understand how to proceed (next steps).\n* Other.\n\nDo your best to follow these copywriting rules:\n- NEVER use any variation of sentences starting with \"I hope this email finds you\" or \"I hope this message finds you\"\n- Be concise and to the point, keep emails below 200 words, if possible\n- Write with assertiveness showing sender's confidence, competence, resilience\n- Include a soft yet clear call-to-action that encourages a response\n- Be unique and do not repeat phrases or sentences from your previous messages\n- Align with recipients' priorities, role, expertise, industry\n- Connect on an emotional level, address buyer's pain points\n- Avoid being \"too salesy\"\n\n\nThe following is the correspondence between the buyer and the seller. The last event in this list is the latest one. The latest event is probably the most important one for making a decision.\n\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 09:45:15.249981."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "content_draft",
          "content_recipients",
          "content_subject"
        ],
        "properties": {
          "content_draft": {
            "type": "string",
            "title": "Content draft"
          },
          "content_subject": {
            "type": "string",
            "title": "Content subject"
          },
          "content_recipients": {
            "type": "array",
            "items": {
              "type": "string"
            },
            "title": "Content recipients"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BfqtYF5DIGuIOZy33tlU7Eb45fCI",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1198,
    "prompt_tokens": 1027,
    "completion_tokens": 171
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"content_draft\":\"Dear Kendall,\\n\\nThank you for sharing the details about Porsolt and your current challenges. It's clear that enhancing visibility and improving conversion rates in the US market are key priorities for you. At Meetings.bio, we specialize in creating tailored outreach strategies that not only increase visibility but also significantly boost conversion rates, especially for companies in the biotech and pharmaceutical sectors.\\n\\nGiven your focus on expanding beyond CNS capabilities, I believe our services could be particularly beneficial. We can help Porsolt stand out in a crowded market and reach your target audience more effectively. I'm looking forward to discussing how we can tailor our approach to meet your specific needs and objectives during our meeting.\\n\\nBest regards,\\nKlemen Hrovat\",\"content_recipients\":[\"Kendall Walker\"],\"content_subject\":\"Looking Forward to Our Meeting\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712569515,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "events": [
    {
      "id": 1639,
      "body": "<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>",
      "type": "meeting",
      "title": "Calendly: Intro to Meetings.bio",
      "sender": null,
      "persons": [
        {
          "emails": [
            "kwalker@porsolt.com"
          ],
          "full_name": "Kendall Walker",
          "last_name": "Walker",
          "first_name": "Kendall",
          "organizations": []
        }
      ],
      "direction": "EventDirection.BIDIRECTIONAL",
      "timestamp": "2024-02-22T22:15:00Z",
      "message_id": null,
      "recipients": null,
      "cc_recipients": null,
      "bcc_recipients": null
    }
  ],
  "offering": null,
  "deal_name": "PORSOLT",
  "prospects": [
    {
      "emails": [
        "kwalker@porsolt.com"
      ],
      "full_name": "Kendall Walker",
      "last_name": "Walker",
      "first_name": "Kendall",
      "organizations": [
        {
          "name": "PORSOLT",
          "domains": [
            "porsolt.com"
          ],
          "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
          "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
        }
      ]
    }
  ],
  "deal_owner_email": "klemen@meetings.bio",
  "primary_prospect": {
    "emails": [
      "kwalker@porsolt.com"
    ],
    "full_name": "Kendall Walker",
    "last_name": "Walker",
    "first_name": "Kendall",
    "organizations": [
      {
        "name": "PORSOLT",
        "domains": [
          "porsolt.com"
        ],
        "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
        "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
      }
    ]
  },
  "deal_owner_full_name": "Klemen Hrovat",
  "deal_owner_last_name": "Hrovat",
  "deal_owner_first_name": "Klemen",
  "deal_owner_customer_name": "Meetings.bio",
  "deal_owner_customer_domain": "meetings.bio",
  "primary_prospect_organization": {
    "name": "PORSOLT",
    "domains": [
      "porsolt.com"
    ],
    "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
    "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
  }
}

{
  "id": 32033,
  "deal": {
    "id": 560,
    "name": "PORSOLT",
    "owner": 2,
    "stage": 4,
    "public_id": "5cf0b743-4b50-4463-9103-a3755838c986",
    "external_id": "17656118199",
    "last_modified_in_crm": null
  },
  "vars": {
    "pipeline_stage": "EXPLORATORY",
    "pipeline_stage_binary": [
      "EXPLORATORY",
      "PROPOSAL"
    ]
  },
  "state": "CREATE_TASK_FOR_EMAIL_RESPONSE",
  "status": "IN_PROGRESS",
  "next_task": 859,
  "events_hash": "bd5f9613eb2b86326a727cc7128859be33783afb",
  "fingerprint": {
    "events": "bd5f9613eb2b86326a727cc7128859be33783afb",
    "offering": "2ef87dc4b9c9e813e0e0433d7547e6b7541d95f5",
    "prospect": "13d1d0befdfe27f64dcf8703ce7bc272ff215882",
    "deal_owner": "ec6bf4d5effdd54ce2a619ab6b933981f503e715"
  },
  "next_task_key": null
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: You are a professional sales person. Your name is Klemen Hrovat. Your task is to respond to the prospect's last email. Make sure to read carefully what the prospect's information goal or intent is, and respond to the best of your knowledge and ability.\n\nThe prospect's intent might be, but is not limited to, one of the following:\n* Postpone the discussion to a later time in the future.\n* Acquire more information about the product or services.\n* Acquire information about pricing.\n* Understand how to proceed (next steps).\n* Other.\n\nDo your best to follow these copywriting rules:\n- NEVER use any variation of sentences starting with \"I hope this email finds you\" or \"I hope this message finds you\"\n- Be concise and to the point, keep emails below 200 words, if possible\n- Write with assertiveness showing sender's confidence, competence, resilience\n- Include a soft yet clear call-to-action that encourages a response\n- Be unique and do not repeat phrases or sentences from your previous messages\n- Align with recipients' priorities, role, expertise, industry\n- Connect on an emotional level, address buyer's pain points\n- Avoid being \"too salesy\"\n\n\nThe following is the correspondence between the buyer and the seller. The last event in this list is the latest one. The latest event is probably the most important one for making a decision.\n\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 09:55:50.851150."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "content_draft",
          "content_recipients",
          "content_subject"
        ],
        "properties": {
          "content_draft": {
            "type": "string",
            "title": "Content draft"
          },
          "content_subject": {
            "type": "string",
            "title": "Content subject"
          },
          "content_recipients": {
            "type": "array",
            "items": {
              "type": "string"
            },
            "title": "Content recipients"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9Bg19S7L2hGdOyui72VOuqX0w08Q0",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1251,
    "prompt_tokens": 1027,
    "completion_tokens": 224
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"content_draft\":\"Dear Kendall,\\n\\nThank you for sharing the details about Porsolt and your current challenges. It's clear that enhancing visibility and improving conversion rates in the US market are key priorities for you. At Meetings.bio, we specialize in creating tailored outreach strategies that not only increase visibility but also significantly boost conversion rates, especially for companies in the biotech and pharmaceutical sectors.\\n\\nGiven your focus on expanding beyond CNS capabilities and the need for a more effective outreach strategy, I believe our services could be a perfect match for your goals. I'm looking forward to discussing how we can tailor our approach to meet Porsolt's specific needs and help you achieve greater traction across various therapeutic portfolios.\\n\\nLet's dive deeper into this during our scheduled meeting. In the meantime, if there's any additional information you need or specific areas you'd like us to focus on, please don't hesitate to reach out.\\n\\nBest regards,\\nKlemen Hrovat\",\"content_recipients\":[\"Kendall Walker\"],\"content_subject\":\"Looking Forward to Our Meeting - Tailoring Outreach for Porsolt\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712570151,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "events": [
    {
      "id": 1639,
      "body": "<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>",
      "type": "meeting",
      "title": "Calendly: Intro to Meetings.bio",
      "sender": null,
      "persons": [
        {
          "emails": [
            "kwalker@porsolt.com"
          ],
          "full_name": "Kendall Walker",
          "last_name": "Walker",
          "first_name": "Kendall",
          "organizations": []
        }
      ],
      "direction": "EventDirection.BIDIRECTIONAL",
      "timestamp": "2024-02-22T22:15:00Z",
      "message_id": null,
      "recipients": null,
      "cc_recipients": null,
      "bcc_recipients": null
    }
  ],
  "offering": null,
  "deal_name": "PORSOLT",
  "prospects": [
    {
      "emails": [
        "kwalker@porsolt.com"
      ],
      "full_name": "Kendall Walker",
      "last_name": "Walker",
      "first_name": "Kendall",
      "organizations": [
        {
          "name": "PORSOLT",
          "domains": [
            "porsolt.com"
          ],
          "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
          "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
        }
      ]
    }
  ],
  "deal_owner_email": "klemen@meetings.bio",
  "primary_prospect": {
    "emails": [
      "kwalker@porsolt.com"
    ],
    "full_name": "Kendall Walker",
    "last_name": "Walker",
    "first_name": "Kendall",
    "organizations": [
      {
        "name": "PORSOLT",
        "domains": [
          "porsolt.com"
        ],
        "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
        "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
      }
    ]
  },
  "deal_owner_full_name": "Klemen Hrovat",
  "deal_owner_last_name": "Hrovat",
  "deal_owner_first_name": "Klemen",
  "deal_owner_customer_name": "Meetings.bio",
  "deal_owner_customer_domain": "meetings.bio",
  "primary_prospect_organization": {
    "name": "PORSOLT",
    "domains": [
      "porsolt.com"
    ],
    "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
    "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
  }
}

{
  "id": 32033,
  "deal": {
    "id": 560,
    "name": "PORSOLT",
    "owner": 2,
    "stage": 4,
    "public_id": "5cf0b743-4b50-4463-9103-a3755838c986",
    "external_id": "17656118199",
    "last_modified_in_crm": null
  },
  "vars": {
    "pipeline_stage": "EXPLORATORY",
    "pipeline_stage_binary": [
      "EXPLORATORY",
      "PROPOSAL"
    ]
  },
  "state": "CREATE_TASK_FOR_EMAIL_RESPONSE",
  "status": "IN_PROGRESS",
  "next_task": 882,
  "events_hash": "bd5f9613eb2b86326a727cc7128859be33783afb",
  "fingerprint": {
    "events": "bd5f9613eb2b86326a727cc7128859be33783afb",
    "offering": "2ef87dc4b9c9e813e0e0433d7547e6b7541d95f5",
    "prospect": "13d1d0befdfe27f64dcf8703ce7bc272ff215882",
    "deal_owner": "ec6bf4d5effdd54ce2a619ab6b933981f503e715"
  },
  "next_task_key": null
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: You are a professional sales person. Your name is Klemen Hrovat. Your task is to respond to the prospect's last email. Make sure to read carefully what the prospect's information goal or intent is, and respond to the best of your knowledge and ability.\n\nThe prospect's intent might be, but is not limited to, one of the following:\n* Postpone the discussion to a later time in the future.\n* Acquire more information about the product or services.\n* Acquire information about pricing.\n* Understand how to proceed (next steps).\n* Other.\n\nDo your best to follow these copywriting rules:\n- NEVER use any variation of sentences starting with \"I hope this email finds you\" or \"I hope this message finds you\"\n- Be concise and to the point, keep emails below 200 words, if possible\n- Write with assertiveness showing sender's confidence, competence, resilience\n- Include a soft yet clear call-to-action that encourages a response\n- Be unique and do not repeat phrases or sentences from your previous messages\n- Align with recipients' priorities, role, expertise, industry\n- Connect on an emotional level, address buyer's pain points\n- Avoid being \"too salesy\"\n\n\nThe following is the correspondence between the buyer and the seller. The last event in this list is the latest one. The latest event is probably the most important one for making a decision.\n\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 10:06:45.463053."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "content_draft",
          "content_recipients",
          "content_subject"
        ],
        "properties": {
          "content_draft": {
            "type": "string",
            "title": "Content draft"
          },
          "content_subject": {
            "type": "string",
            "title": "Content subject"
          },
          "content_recipients": {
            "type": "array",
            "items": {
              "type": "string"
            },
            "title": "Content recipients"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BgBhUXDCxZH8dmouZSIjJOZIgLVD",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1195,
    "prompt_tokens": 1027,
    "completion_tokens": 168
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"content_draft\":\"Dear Kendall,\\n\\nThank you for sharing the details about Porsolt and your current challenges. It's clear that enhancing visibility and improving conversion rates in the US market are key priorities for you. At Meetings.bio, we specialize in optimizing outreach strategies to ensure our clients not only gain visibility but also achieve higher conversion rates, especially in new therapeutic areas.\\n\\nI'm looking forward to our meeting to discuss how we can tailor our services to meet Porsolt's specific needs and help you overcome the hurdles in your outreach strategy. In the meantime, if there's any additional information or specific concerns you'd like to address, please don't hesitate to reach out.\\n\\nBest regards,\\nKlemen Hrovat\",\"content_recipients\":[\"Kendall Walker\"],\"content_subject\":\"Looking Forward to Our Meeting\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712570805,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "events": [
    {
      "id": 1639,
      "body": "<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>",
      "type": "meeting",
      "title": "Calendly: Intro to Meetings.bio",
      "sender": null,
      "persons": [
        {
          "emails": [
            "kwalker@porsolt.com"
          ],
          "full_name": "Kendall Walker",
          "last_name": "Walker",
          "first_name": "Kendall",
          "organizations": []
        }
      ],
      "direction": "EventDirection.BIDIRECTIONAL",
      "timestamp": "2024-02-22T22:15:00Z",
      "message_id": null,
      "recipients": null,
      "cc_recipients": null,
      "bcc_recipients": null
    }
  ],
  "offering": null,
  "deal_name": "PORSOLT",
  "prospects": [
    {
      "emails": [
        "kwalker@porsolt.com"
      ],
      "full_name": "Kendall Walker",
      "last_name": "Walker",
      "first_name": "Kendall",
      "organizations": [
        {
          "name": "PORSOLT",
          "domains": [
            "porsolt.com"
          ],
          "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
          "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
        }
      ]
    }
  ],
  "deal_owner_email": "klemen@meetings.bio",
  "primary_prospect": {
    "emails": [
      "kwalker@porsolt.com"
    ],
    "full_name": "Kendall Walker",
    "last_name": "Walker",
    "first_name": "Kendall",
    "organizations": [
      {
        "name": "PORSOLT",
        "domains": [
          "porsolt.com"
        ],
        "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
        "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
      }
    ]
  },
  "deal_owner_full_name": "Klemen Hrovat",
  "deal_owner_last_name": "Hrovat",
  "deal_owner_first_name": "Klemen",
  "deal_owner_customer_name": "Meetings.bio",
  "deal_owner_customer_domain": "meetings.bio",
  "primary_prospect_organization": {
    "name": "PORSOLT",
    "domains": [
      "porsolt.com"
    ],
    "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
    "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
  }
}

{
  "id": 32033,
  "deal": {
    "id": 560,
    "name": "PORSOLT",
    "owner": 2,
    "stage": 4,
    "public_id": "5cf0b743-4b50-4463-9103-a3755838c986",
    "external_id": "17656118199",
    "last_modified_in_crm": null
  },
  "vars": {
    "pipeline_stage": "EXPLORATORY",
    "pipeline_stage_binary": [
      "EXPLORATORY",
      "PROPOSAL"
    ]
  },
  "state": "CREATE_TASK_FOR_EMAIL_RESPONSE",
  "status": "IN_PROGRESS",
  "next_task": 896,
  "events_hash": "bd5f9613eb2b86326a727cc7128859be33783afb",
  "fingerprint": {
    "events": "bd5f9613eb2b86326a727cc7128859be33783afb",
    "offering": "2ef87dc4b9c9e813e0e0433d7547e6b7541d95f5",
    "prospect": "13d1d0befdfe27f64dcf8703ce7bc272ff215882",
    "deal_owner": "ec6bf4d5effdd54ce2a619ab6b933981f503e715"
  },
  "next_task_key": null
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: You are a professional sales email writer. Your task is to respond (reply) to the last buyer's email. This email will be sent by the seller Klemen Hrovat from Meetings.bio. Be mindful of the fact that the buyer has most likely sent the last email with a clear information goal. The email needs to have the following components:\n\n* subject_line - Email subject line. Short and to the point.\n\n* recipients - List of recipients of this email. Be careful to only include the recipients (or one single recipient) with which you were communicating in the last email exchanges. Do not add other recipients if not explicitly requested or required.\n\n* greeting - Salutation. Greets the recipients of this email. It is important to inspect the past conversation and address the recipients in a similar manner when it comes to the register. Consider only short greetings like \"Hi (recipient's first name),\" or \"Dear Dr. (recipient's surname),\" depending on the chosen register.\n\n* opening_line - The opening line of the email. It should be a continuation of the greeting and should be a short sentence that leads to the body of the email. The opening line should be between 10 and 20 words.\n\n\n* body - The body of the email. To write the body, follow these rules:\n  - Needs to address the buyer's questions or concerns.\n  - Be mindful of the fact that the buyer has most likely sent the last email with a clear information goal. The buyer's intent might be (but is not limited to) one of the following: postpone the discussion to a later time in the future; acquire more information about the product or services; acquire information about pricing; understand how to proceed (next steps); something else.\n  - Whenever possible, talk about time in relative terms (last week, yesterday, two days ago...) rather than absolute. \n  - Do **NOT** start the body with \"I hope this email finds you well\", \"We haven't had a chance to connect\", \"I haven't heard from you\", \"touching base\", \"just checking in\", \"wanted to circle back\", and similar email openings as they provide no value to the recipient. Simply start with the main message, do not include any uninformative opening sentence. \n  - Do not start the first sentence with \"Following our last conversation\" or a something similar. Simply omit this part and go straight to the point.\n  - Do not include any opening or closing statements in the body. Limit the body only to informative and to the point content. \n  - Mimic the register from the past conversation. \n  - Do not repeat information or courtesy sentences from the previous emails. \n  - The length of the body should be between 100 and 250 words. If formulating a response to the buyer's enquiry requires more words, it is acceptable to go over this limit. \n  - Go straight to the point without too much fluff, but keep it kind and polite.\n\n* closing - A courtesy closing statement. Tell the recipient that you are looking forward to their reply. Keep it very short, one short sentence only.\n\n* signature - Sender's signature. Only include a very basic farewell-line like \"Thanks, Klemen\", \"Best, Klemen\", \"Regards, Klemen\". Do NOT generate full Klemen Hrovat's signature.\n\n--\n\nALSO IMPORTANT:\n\n* Carefully examine the last communication event from the prospect (buyer) and the last communication event from the seller. These two events will give you the most relevant information on how to write your email.\n* Do not repeat information or courtesy sentences from the previous emails that the seller has already sent. For example, if the seller already expressed best new year's wishes in the previous email, do not repeat them in this email.\n* The email content needs to be in the same language as the rest of the communication in the context.\n\n\nThe following is the correspondence between the buyer and the seller. The last event in this list is the latest one. The latest event is probably the most important one for making a decision.\n\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 10:44:09.041808."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "subject_line",
          "recipients",
          "greeting",
          "opening_line",
          "body",
          "closing",
          "signature"
        ],
        "properties": {
          "body": {
            "type": "string",
            "title": "Body"
          },
          "closing": {
            "type": "string",
            "title": "Closing"
          },
          "greeting": {
            "type": "string",
            "title": "Greeting"
          },
          "signature": {
            "type": "string",
            "title": "Signature"
          },
          "recipients": {
            "type": "array",
            "items": {
              "type": "string"
            },
            "title": "Recipients"
          },
          "opening_line": {
            "type": "string",
            "title": "Opening line"
          },
          "subject_line": {
            "type": "string",
            "title": "Subject line"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BgltmxVbV4S9uIJXqRHfUyIbmh5x",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1834,
    "prompt_tokens": 1602,
    "completion_tokens": 232
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"subject_line\":\"Strategies for Enhancing PORSOLT's US Outreach\",\"recipients\":[\"kendall@porsolt.com\"],\"greeting\":\"Hi Kendall,\",\"opening_line\":\"Thank you for sharing the details about PORSOLT's current challenges.\",\"body\":\"Understanding your need to improve visibility and traction across various therapeutic portfolios in the US, especially beyond your renowned CNS capabilities, it's clear that a more effective outreach strategy is essential. Our platform, Meetings.bio, is designed to enhance engagement with both cold leads and established contacts by leveraging advanced analytics and personalized communication strategies. We can help PORSOLT tailor its approach to better resonate with the US market, focusing on areas where your services are most needed but perhaps not as well recognized. By analyzing your current outreach efforts and the market's response, we can identify key areas for improvement and implement a more targeted strategy. This could involve a mix of content marketing, strategic partnerships, and direct outreach, all aimed at highlighting PORSOLT's broad range of services and expertise in a way that captivates your target audience.\",\"closing\":\"Looking forward to discussing this further.\",\"signature\":\"Best, Klemen\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712573049,
  "system_fingerprint": "fp_1fbd2f868d"
}

{
  "events": [
    {
      "id": 1639,
      "body": "<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>",
      "type": "meeting",
      "title": "Calendly: Intro to Meetings.bio",
      "sender": null,
      "persons": [
        {
          "emails": [
            "kwalker@porsolt.com"
          ],
          "full_name": "Kendall Walker",
          "last_name": "Walker",
          "first_name": "Kendall",
          "organizations": []
        }
      ],
      "direction": "EventDirection.BIDIRECTIONAL",
      "timestamp": "2024-02-22T22:15:00Z",
      "message_id": null,
      "recipients": null,
      "cc_recipients": null,
      "bcc_recipients": null
    }
  ],
  "offering": null,
  "deal_name": "PORSOLT",
  "prospects": [
    {
      "emails": [
        "kwalker@porsolt.com"
      ],
      "full_name": "Kendall Walker",
      "last_name": "Walker",
      "first_name": "Kendall",
      "organizations": [
        {
          "name": "PORSOLT",
          "domains": [
            "porsolt.com"
          ],
          "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
          "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
        }
      ]
    }
  ],
  "deal_owner_email": "klemen@meetings.bio",
  "primary_prospect": {
    "emails": [
      "kwalker@porsolt.com"
    ],
    "full_name": "Kendall Walker",
    "last_name": "Walker",
    "first_name": "Kendall",
    "organizations": [
      {
        "name": "PORSOLT",
        "domains": [
          "porsolt.com"
        ],
        "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
        "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
      }
    ]
  },
  "deal_owner_full_name": "Klemen Hrovat",
  "deal_owner_last_name": "Hrovat",
  "deal_owner_first_name": "Klemen",
  "deal_owner_customer_name": "Meetings.bio",
  "deal_owner_customer_domain": "meetings.bio",
  "primary_prospect_organization": {
    "name": "PORSOLT",
    "domains": [
      "porsolt.com"
    ],
    "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
    "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
  }
}

{
  "id": 32033,
  "deal": {
    "id": 560,
    "name": "PORSOLT",
    "owner": 2,
    "stage": 4,
    "public_id": "5cf0b743-4b50-4463-9103-a3755838c986",
    "external_id": "17656118199",
    "last_modified_in_crm": null
  },
  "vars": {
    "pipeline_stage": "EXPLORATORY",
    "pipeline_stage_binary": [
      "EXPLORATORY",
      "PROPOSAL"
    ]
  },
  "state": "CREATE_TASK_FOR_EMAIL_RESPONSE",
  "status": "IN_PROGRESS",
  "next_task": 921,
  "events_hash": "bd5f9613eb2b86326a727cc7128859be33783afb",
  "fingerprint": {
    "events": "bd5f9613eb2b86326a727cc7128859be33783afb",
    "offering": "2ef87dc4b9c9e813e0e0433d7547e6b7541d95f5",
    "prospect": "13d1d0befdfe27f64dcf8703ce7bc272ff215882",
    "deal_owner": "ec6bf4d5effdd54ce2a619ab6b933981f503e715"
  },
  "next_task_key": null
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: You are a professional sales email writer. Your task is to respond (reply) to the last buyer's email. This email will be sent by the seller Klemen Hrovat from Meetings.bio. Be mindful of the fact that the buyer has most likely sent the last email with a clear information goal. The email needs to have the following components:\n\n* subject_line - Email subject line. Short and to the point.\n\n* recipients - List of recipients of this email. Be careful to only include the recipients (or one single recipient) with which you were communicating in the last email exchanges. Do not add other recipients if not explicitly requested or required.\n\n* greeting - Salutation. Greets the recipients of this email. It is important to inspect the past conversation and address the recipients in a similar manner when it comes to the register. Consider only short greetings like \"Hi (recipient's first name),\" or \"Dear Dr. (recipient's surname),\" depending on the chosen register.\n\n* opening_line - The opening line of the email. It should be a continuation of the greeting and should be a short sentence that leads to the body of the email. The opening line should be between 10 and 20 words.\n\n\n* body - The body of the email. To write the body, follow these rules:\n  - Needs to address the buyer's questions or concerns.\n  - Be mindful of the fact that the buyer has most likely sent the last email with a clear information goal. The buyer's intent might be (but is not limited to) one of the following: postpone the discussion to a later time in the future; acquire more information about the product or services; acquire information about pricing; understand how to proceed (next steps); something else.\n  - Whenever possible, talk about time in relative terms (last week, yesterday, two days ago...) rather than absolute. \n  - Do **NOT** start the body with \"I hope this email finds you well\", \"We haven't had a chance to connect\", \"I haven't heard from you\", \"touching base\", \"just checking in\", \"wanted to circle back\", and similar email openings as they provide no value to the recipient. Simply start with the main message, do not include any uninformative opening sentence. \n  - Do not start the first sentence with \"Following our last conversation\" or a something similar. Simply omit this part and go straight to the point.\n  - Do not include any opening or closing statements in the body. Limit the body only to informative and to the point content. \n  - Mimic the register from the past conversation. \n  - Do not repeat information or courtesy sentences from the previous emails. \n  - The length of the body should be between 100 and 250 words. If formulating a response to the buyer's enquiry requires more words, it is acceptable to go over this limit. \n  - Go straight to the point without too much fluff, but keep it kind and polite.\n\n* closing - A courtesy closing statement. Tell the recipient that you are looking forward to their reply. Keep it very short, one short sentence only.\n\n* signature - Sender's signature. Only include a very basic farewell-line like \"Thanks, Klemen\", \"Best, Klemen\", \"Regards, Klemen\". Do NOT generate full Klemen Hrovat's signature.\n\n--\n\nALSO IMPORTANT:\n\n* Carefully examine the last communication event from the prospect (buyer) and the last communication event from the seller. These two events will give you the most relevant information on how to write your email.\n* Do not repeat information or courtesy sentences from the previous emails that the seller has already sent. For example, if the seller already expressed best new year's wishes in the previous email, do not repeat them in this email.\n* The email content needs to be in the same language as the rest of the communication in the context.\n\n\nThe following is the correspondence between the buyer and the seller. The last event in this list is the latest one. The latest event is probably the most important one for making a decision.\n\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 11:07:21.761615."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "subject_line",
          "recipients",
          "greeting",
          "opening_line",
          "body",
          "closing",
          "signature"
        ],
        "properties": {
          "body": {
            "type": "string",
            "title": "Body"
          },
          "closing": {
            "type": "string",
            "title": "Closing"
          },
          "greeting": {
            "type": "string",
            "title": "Greeting"
          },
          "signature": {
            "type": "string",
            "title": "Signature"
          },
          "recipients": {
            "type": "array",
            "items": {
              "type": "string"
            },
            "title": "Recipients"
          },
          "opening_line": {
            "type": "string",
            "title": "Opening line"
          },
          "subject_line": {
            "type": "string",
            "title": "Subject line"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9Bh8MdiZuuuM29sWEhtQ8B9MxtZel",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1796,
    "prompt_tokens": 1602,
    "completion_tokens": 194
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"subject_line\":\"Strategies for Enhancing PORSOLT's US Outreach\",\"recipients\":[\"kendall@porsolt.com\"],\"greeting\":\"Hi Kendall,\",\"opening_line\":\"Thank you for sharing the details about PORSOLT's current challenges.\",\"body\":\"Understanding your need to improve visibility and traction across various therapeutic portfolios in the US, especially beyond your renowned CNS capabilities, we believe Meetings.bio can offer a tailored solution. Our platform specializes in enhancing outreach strategies through targeted engagement and data-driven insights, which could significantly increase your conversion rates with cold leads. By leveraging our tools, PORSOLT can not only expand its visibility but also ensure that your outreach efforts are more aligned with the interests and needs of your potential clients. We're keen to discuss how our services can be specifically adapted to meet PORSOLT's unique requirements and help you achieve your desired outcomes in the US market.\",\"closing\":\"Looking forward to your thoughts.\",\"signature\":\"Best, Klemen\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712574442,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "events": [
    {
      "id": 1639,
      "body": "<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>",
      "type": "meeting",
      "title": "Calendly: Intro to Meetings.bio",
      "sender": null,
      "persons": [
        {
          "emails": [
            "kwalker@porsolt.com"
          ],
          "full_name": "Kendall Walker",
          "last_name": "Walker",
          "first_name": "Kendall",
          "organizations": []
        }
      ],
      "direction": "EventDirection.BIDIRECTIONAL",
      "timestamp": "2024-02-22T22:15:00Z",
      "message_id": null,
      "recipients": null,
      "cc_recipients": null,
      "bcc_recipients": null
    }
  ],
  "offering": null,
  "deal_name": "PORSOLT",
  "prospects": [
    {
      "emails": [
        "kwalker@porsolt.com"
      ],
      "full_name": "Kendall Walker",
      "last_name": "Walker",
      "first_name": "Kendall",
      "organizations": [
        {
          "name": "PORSOLT",
          "domains": [
            "porsolt.com"
          ],
          "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
          "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
        }
      ]
    }
  ],
  "deal_owner_email": "klemen@meetings.bio",
  "primary_prospect": {
    "emails": [
      "kwalker@porsolt.com"
    ],
    "full_name": "Kendall Walker",
    "last_name": "Walker",
    "first_name": "Kendall",
    "organizations": [
      {
        "name": "PORSOLT",
        "domains": [
          "porsolt.com"
        ],
        "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
        "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
      }
    ]
  },
  "deal_owner_full_name": "Klemen Hrovat",
  "deal_owner_last_name": "Hrovat",
  "deal_owner_first_name": "Klemen",
  "deal_owner_customer_name": "Meetings.bio",
  "deal_owner_customer_domain": "meetings.bio",
  "primary_prospect_organization": {
    "name": "PORSOLT",
    "domains": [
      "porsolt.com"
    ],
    "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
    "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
  }
}

{
  "id": 32033,
  "deal": {
    "id": 560,
    "name": "PORSOLT",
    "owner": 2,
    "stage": 4,
    "public_id": "5cf0b743-4b50-4463-9103-a3755838c986",
    "external_id": "17656118199",
    "last_modified_in_crm": null
  },
  "vars": {
    "pipeline_stage": "EXPLORATORY",
    "pipeline_stage_binary": [
      "EXPLORATORY",
      "PROPOSAL"
    ]
  },
  "state": "CREATE_TASK_FOR_EMAIL_RESPONSE",
  "status": "IN_PROGRESS",
  "next_task": 953,
  "events_hash": "bd5f9613eb2b86326a727cc7128859be33783afb",
  "fingerprint": {
    "events": "bd5f9613eb2b86326a727cc7128859be33783afb",
    "offering": "2ef87dc4b9c9e813e0e0433d7547e6b7541d95f5",
    "prospect": "13d1d0befdfe27f64dcf8703ce7bc272ff215882",
    "deal_owner": "ec6bf4d5effdd54ce2a619ab6b933981f503e715"
  },
  "next_task_key": null
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: You are a professional sales email writer. Your task is to respond (reply) to the last buyer's email. This email will be sent by the seller Klemen Hrovat from Meetings.bio. Be mindful of the fact that the buyer has most likely sent the last email with a clear information goal. The email needs to have the following components:\n\n* subject_line - Email subject line. Short and to the point.\n\n* recipients - List of recipients of this email. Be careful to only include the recipients (or one single recipient) with which you were communicating in the last email exchanges. Do not add other recipients if not explicitly requested or required.\n\n* greeting - Salutation. Greets the recipients of this email. It is important to inspect the past conversation and address the recipients in a similar manner when it comes to the register. Consider only short greetings like \"Hi (recipient's first name),\" or \"Dear Dr. (recipient's surname),\" depending on the chosen register.\n\n* opening_line - The opening line of the email. It should be a continuation of the greeting and should be a short sentence that leads to the body of the email. The opening line should be between 10 and 20 words.\n\n\n* body - The body of the email. To write the body, follow these rules:\n  - Needs to address the buyer's questions or concerns.\n  - Be mindful of the fact that the buyer has most likely sent the last email with a clear information goal. The buyer's intent might be (but is not limited to) one of the following: postpone the discussion to a later time in the future; acquire more information about the product or services; acquire information about pricing; understand how to proceed (next steps); something else.\n  - Whenever possible, talk about time in relative terms (last week, yesterday, two days ago...) rather than absolute. \n  - Do **NOT** start the body with \"I hope this email finds you well\", \"We haven't had a chance to connect\", \"I haven't heard from you\", \"touching base\", \"just checking in\", \"wanted to circle back\", and similar email openings as they provide no value to the recipient. Simply start with the main message, do not include any uninformative opening sentence. \n  - Do not start the first sentence with \"Following our last conversation\" or a something similar. Simply omit this part and go straight to the point.\n  - Do not include any opening or closing statements in the body. Limit the body only to informative and to the point content. \n  - Mimic the register from the past conversation. \n  - Do not repeat information or courtesy sentences from the previous emails. \n  - The length of the body should be between 100 and 250 words. If formulating a response to the buyer's enquiry requires more words, it is acceptable to go over this limit. \n  - Go straight to the point without too much fluff, but keep it kind and polite.\n\n* closing - A courtesy closing statement. Tell the recipient that you are looking forward to their reply. Keep it very short, one short sentence only.\n\n* signature - Sender's signature. Only include a very basic farewell-line like \"Thanks, Klemen\", \"Best, Klemen\", \"Regards, Klemen\". Do NOT generate full Klemen Hrovat's signature.\n\n--\n\nALSO IMPORTANT:\n\n* Carefully examine the last communication event from the prospect (buyer) and the last communication event from the seller. These two events will give you the most relevant information on how to write your email.\n* Do not repeat information or courtesy sentences from the previous emails that the seller has already sent. For example, if the seller already expressed best new year's wishes in the previous email, do not repeat them in this email.\n* The email content needs to be in the same language as the rest of the communication in the context.\n\n\nThe following is the correspondence between the buyer and the seller. The last event in this list is the latest one. The latest event is probably the most important one for making a decision.\n\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 11:17:44.611392."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "subject_line",
          "recipients",
          "greeting",
          "opening_line",
          "body",
          "closing",
          "signature"
        ],
        "properties": {
          "body": {
            "type": "string",
            "title": "Body"
          },
          "closing": {
            "type": "string",
            "title": "Closing"
          },
          "greeting": {
            "type": "string",
            "title": "Greeting"
          },
          "signature": {
            "type": "string",
            "title": "Signature"
          },
          "recipients": {
            "type": "array",
            "items": {
              "type": "string"
            },
            "title": "Recipients"
          },
          "opening_line": {
            "type": "string",
            "title": "Opening line"
          },
          "subject_line": {
            "type": "string",
            "title": "Subject line"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BhIPWs1bmKMNzf55GKunt7ojnc6b",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1800,
    "prompt_tokens": 1602,
    "completion_tokens": 198
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"subject_line\":\"Enhancing PORSOLT's Outreach Strategy\",\"recipients\":[\"kendall@porsolt.com\"],\"greeting\":\"Hi Kendall,\",\"opening_line\":\"Thank you for sharing the details about PORSOLT's current outreach challenges.\",\"body\":\"It's clear that enhancing visibility and conversion rates in the US market is a priority for PORSOLT, especially beyond your renowned CNS capabilities. At Meetings.bio, we specialize in creating tailored outreach strategies that not only increase visibility but also significantly improve conversion rates. Our approach involves a deep dive into your current strategy, identifying gaps, and leveraging our extensive network and innovative tools to target the right audience more effectively. Given your goal to expand visibility across various therapeutic portfolios, we can focus on strategic areas that align with your strengths and market demand. Let's discuss how we can customize a plan that fits PORSOLT's unique needs and objectives during our upcoming meeting.\",\"closing\":\"Looking forward to our discussion.\",\"signature\":\"Best, Klemen\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712575065,
  "system_fingerprint": "fp_21e53d6942"
}

{
  "events": [
    {
      "id": 1639,
      "body": "<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>",
      "type": "meeting",
      "title": "Calendly: Intro to Meetings.bio",
      "sender": null,
      "persons": [
        {
          "emails": [
            "kwalker@porsolt.com"
          ],
          "full_name": "Kendall Walker",
          "last_name": "Walker",
          "first_name": "Kendall",
          "organizations": []
        }
      ],
      "direction": "EventDirection.BIDIRECTIONAL",
      "timestamp": "2024-02-22T22:15:00Z",
      "message_id": null,
      "recipients": null,
      "cc_recipients": null,
      "bcc_recipients": null
    }
  ],
  "offering": null,
  "deal_name": "PORSOLT",
  "prospects": [
    {
      "emails": [
        "kwalker@porsolt.com"
      ],
      "full_name": "Kendall Walker",
      "last_name": "Walker",
      "first_name": "Kendall",
      "organizations": [
        {
          "name": "PORSOLT",
          "domains": [
            "porsolt.com"
          ],
          "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
          "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
        }
      ]
    }
  ],
  "deal_owner_email": "klemen@meetings.bio",
  "primary_prospect": {
    "emails": [
      "kwalker@porsolt.com"
    ],
    "full_name": "Kendall Walker",
    "last_name": "Walker",
    "first_name": "Kendall",
    "organizations": [
      {
        "name": "PORSOLT",
        "domains": [
          "porsolt.com"
        ],
        "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
        "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
      }
    ]
  },
  "deal_owner_full_name": "Klemen Hrovat",
  "deal_owner_last_name": "Hrovat",
  "deal_owner_first_name": "Klemen",
  "deal_owner_customer_name": "Meetings.bio",
  "deal_owner_customer_domain": "meetings.bio",
  "primary_prospect_organization": {
    "name": "PORSOLT",
    "domains": [
      "porsolt.com"
    ],
    "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
    "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
  }
}

{
  "id": 32033,
  "deal": {
    "id": 560,
    "name": "PORSOLT",
    "owner": 2,
    "stage": 4,
    "public_id": "5cf0b743-4b50-4463-9103-a3755838c986",
    "external_id": "17656118199",
    "last_modified_in_crm": null
  },
  "vars": {
    "pipeline_stage": "EXPLORATORY",
    "pipeline_stage_binary": [
      "EXPLORATORY",
      "PROPOSAL"
    ]
  },
  "state": "CREATE_TASK_FOR_EMAIL_RESPONSE",
  "status": "IN_PROGRESS",
  "next_task": 977,
  "events_hash": "bd5f9613eb2b86326a727cc7128859be33783afb",
  "fingerprint": {
    "events": "bd5f9613eb2b86326a727cc7128859be33783afb",
    "offering": "2ef87dc4b9c9e813e0e0433d7547e6b7541d95f5",
    "prospect": "13d1d0befdfe27f64dcf8703ce7bc272ff215882",
    "deal_owner": "ec6bf4d5effdd54ce2a619ab6b933981f503e715"
  },
  "next_task_key": null
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: You are a professional sales email writer. Your task is to respond (reply) to the last buyer's email. This email will be sent by the seller Klemen Hrovat from Meetings.bio. Be mindful of the fact that the buyer has most likely sent the last email with a clear information goal. The email needs to have the following components:\n\n* subject_line - Email subject line. Short and to the point.\n\n* recipients - List of recipients of this email. Be careful to only include the recipients (or one single recipient) with which you were communicating in the last email exchanges. Do not add other recipients if not explicitly requested or required.\n\n* greeting - Salutation. Greets the recipients of this email. It is important to inspect the past conversation and address the recipients in a similar manner when it comes to the register. Consider only short greetings like \"Hi (recipient's first name),\" or \"Dear Dr. (recipient's surname),\" depending on the chosen register.\n\n* opening_line - The opening line of the email. It should be a continuation of the greeting and should be a short sentence that leads to the body of the email. The opening line should be between 10 and 20 words.\n\n\n* body - The body of the email. To write the body, follow these rules:\n  - Needs to address the buyer's questions or concerns.\n  - Be mindful of the fact that the buyer has most likely sent the last email with a clear information goal. The buyer's intent might be (but is not limited to) one of the following: postpone the discussion to a later time in the future; acquire more information about the product or services; acquire information about pricing; understand how to proceed (next steps); something else.\n  - Whenever possible, talk about time in relative terms (last week, yesterday, two days ago...) rather than absolute. \n  - Do **NOT** start the body with \"I hope this email finds you well\", \"We haven't had a chance to connect\", \"I haven't heard from you\", \"touching base\", \"just checking in\", \"wanted to circle back\", and similar email openings as they provide no value to the recipient. Simply start with the main message, do not include any uninformative opening sentence. \n  - Do not start the first sentence with \"Following our last conversation\" or a something similar. Simply omit this part and go straight to the point.\n  - Do not include any opening or closing statements in the body. Limit the body only to informative and to the point content. \n  - Mimic the register from the past conversation. \n  - Do not repeat information or courtesy sentences from the previous emails. \n  - The length of the body should be between 100 and 250 words. If formulating a response to the buyer's enquiry requires more words, it is acceptable to go over this limit. \n  - Go straight to the point without too much fluff, but keep it kind and polite.\n\n* closing - A courtesy closing statement. Tell the recipient that you are looking forward to their reply. Keep it very short, one short sentence only.\n\n* signature - Sender's signature. Only include a very basic farewell-line like \"Thanks, Klemen\", \"Best, Klemen\", \"Regards, Klemen\". Do NOT generate full Klemen Hrovat's signature.\n\n--\n\nALSO IMPORTANT:\n\n* Carefully examine the last communication event from the prospect (buyer) and the last communication event from the seller. These two events will give you the most relevant information on how to write your email.\n* Do not repeat information or courtesy sentences from the previous emails that the seller has already sent. For example, if the seller already expressed best new year's wishes in the previous email, do not repeat them in this email.\n* The email content needs to be in the same language as the rest of the communication in the context.\n\n\nThe following is the correspondence between the buyer and the seller. The last event in this list is the latest one. The latest event is probably the most important one for making a decision.\n\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-08 11:45:10.527031."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "subject_line",
          "recipients",
          "greeting",
          "opening_line",
          "body",
          "closing",
          "signature"
        ],
        "properties": {
          "body": {
            "type": "string",
            "title": "Body"
          },
          "closing": {
            "type": "string",
            "title": "Closing"
          },
          "greeting": {
            "type": "string",
            "title": "Greeting"
          },
          "signature": {
            "type": "string",
            "title": "Signature"
          },
          "recipients": {
            "type": "array",
            "items": {
              "type": "string"
            },
            "title": "Recipients"
          },
          "opening_line": {
            "type": "string",
            "title": "Opening line"
          },
          "subject_line": {
            "type": "string",
            "title": "Subject line"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "chatcmpl-9BhixMsWd2l9R3TA7T6RyfBilbehT",
  "model": "gpt-4-0125-preview",
  "usage": {
    "total_tokens": 1785,
    "prompt_tokens": 1602,
    "completion_tokens": 183
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"subject_line\":\"Maximizing Your Outreach with Meetings.bio\",\"recipients\":[\"kendall@porsolt.com\"],\"greeting\":\"Hi Kendall,\",\"opening_line\":\"Thank you for sharing details about Porsolt in our upcoming meeting.\",\"body\":\"Understanding your current challenges with outreach in the US, especially in expanding visibility and traction beyond CNS capabilities, Meetings.bio can offer tailored solutions. Our platform specializes in enhancing engagement with cold leads through personalized communication and analytics-driven strategies. By leveraging our tools, Porsolt can increase its conversion rates and effectively reach a broader client base across various therapeutic areas. We're keen to explore how our services can align with your goals and address the specific needs of your outreach strategy. Let's discuss how we can tailor our approach to fit Porsolt's unique position in the market and drive meaningful results.\",\"closing\":\"Looking forward to our discussion.\",\"signature\":\"Best, Klemen\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712576711,
  "system_fingerprint": "fp_b77cb481ed"
}

{
  "events": [
    {
      "id": 1639,
      "body": "<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>",
      "type": "meeting",
      "title": "Calendly: Intro to Meetings.bio",
      "sender": null,
      "persons": [
        {
          "emails": [
            "kwalker@porsolt.com"
          ],
          "full_name": "Kendall Walker",
          "last_name": "Walker",
          "first_name": "Kendall",
          "organizations": []
        }
      ],
      "direction": "EventDirection.BIDIRECTIONAL",
      "timestamp": "2024-02-22T22:15:00Z",
      "message_id": null,
      "recipients": null,
      "cc_recipients": null,
      "bcc_recipients": null
    }
  ],
  "offering": null,
  "deal_name": "PORSOLT",
  "prospects": [
    {
      "emails": [
        "kwalker@porsolt.com"
      ],
      "full_name": "Kendall Walker",
      "last_name": "Walker",
      "first_name": "Kendall",
      "organizations": [
        {
          "name": "PORSOLT",
          "domains": [
            "porsolt.com"
          ],
          "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
          "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
        }
      ]
    }
  ],
  "deal_owner_email": "klemen@meetings.bio",
  "primary_prospect": {
    "emails": [
      "kwalker@porsolt.com"
    ],
    "full_name": "Kendall Walker",
    "last_name": "Walker",
    "first_name": "Kendall",
    "organizations": [
      {
        "name": "PORSOLT",
        "domains": [
          "porsolt.com"
        ],
        "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
        "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
      }
    ]
  },
  "deal_owner_full_name": "Klemen Hrovat",
  "deal_owner_last_name": "Hrovat",
  "deal_owner_first_name": "Klemen",
  "deal_owner_customer_name": "Meetings.bio",
  "deal_owner_customer_domain": "meetings.bio",
  "primary_prospect_organization": {
    "name": "PORSOLT",
    "domains": [
      "porsolt.com"
    ],
    "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
    "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
  }
}

{
  "id": 32033,
  "deal": {
    "id": 560,
    "name": "PORSOLT",
    "owner": 2,
    "stage": 4,
    "public_id": "5cf0b743-4b50-4463-9103-a3755838c986",
    "external_id": "17656118199",
    "last_modified_in_crm": null
  },
  "vars": {
    "pipeline_stage": "EXPLORATORY",
    "pipeline_stage_binary": [
      "EXPLORATORY",
      "PROPOSAL"
    ]
  },
  "state": "CREATE_TASK_FOR_EMAIL_RESPONSE",
  "status": "IN_PROGRESS",
  "next_task": 1002,
  "events_hash": "bd5f9613eb2b86326a727cc7128859be33783afb",
  "fingerprint": {
    "events": "bd5f9613eb2b86326a727cc7128859be33783afb",
    "offering": "2ef87dc4b9c9e813e0e0433d7547e6b7541d95f5",
    "prospect": "13d1d0befdfe27f64dcf8703ce7bc272ff215882",
    "deal_owner": "ec6bf4d5effdd54ce2a619ab6b933981f503e715"
  },
  "next_task_key": null
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: You are a professional sales email writer. Your task is to respond (reply) to the last buyer's email. This email will be sent by the seller Klemen Hrovat from Meetings.bio. Be mindful of the fact that the buyer has most likely sent the last email with a clear information goal. The email needs to have the following components:\n\n* subject_line - Email subject line. Short and to the point.\n\n* recipients - List of recipients of this email. Be careful to only include the recipients (or one single recipient) with which you were communicating in the last email exchanges. Do not add other recipients if not explicitly requested or required.\n\n* greeting - Salutation. Greets the recipients of this email. It is important to inspect the past conversation and address the recipients in a similar manner when it comes to the register. Consider only short greetings like \"Hi (recipient's first name),\" or \"Dear Dr. (recipient's surname),\" depending on the chosen register.\n\n* opening_line - The opening line of the email. It should be a continuation of the greeting and should be a short sentence that leads to the body of the email. The opening line should be between 10 and 20 words.\n\n\n* body - The body of the email. To write the body, follow these rules:\n  - Needs to address the buyer's questions or concerns.\n  - Be mindful of the fact that the buyer has most likely sent the last email with a clear information goal. The buyer's intent might be (but is not limited to) one of the following: postpone the discussion to a later time in the future; acquire more information about the product or services; acquire information about pricing; understand how to proceed (next steps); something else.\n  - Whenever possible, talk about time in relative terms (last week, yesterday, two days ago...) rather than absolute. \n  - Do **NOT** start the body with \"I hope this email finds you well\", \"We haven't had a chance to connect\", \"I haven't heard from you\", \"touching base\", \"just checking in\", \"wanted to circle back\", and similar email openings as they provide no value to the recipient. Simply start with the main message, do not include any uninformative opening sentence. \n  - Do not start the first sentence with \"Following our last conversation\" or a something similar. Simply omit this part and go straight to the point.\n  - Do not include any opening or closing statements in the body. Limit the body only to informative and to the point content. \n  - Mimic the register from the past conversation. \n  - Do not repeat information or courtesy sentences from the previous emails. \n  - The length of the body should be between 100 and 250 words. If formulating a response to the buyer's enquiry requires more words, it is acceptable to go over this limit. \n  - Go straight to the point without too much fluff, but keep it kind and polite.\n\n* closing - A courtesy closing statement. Tell the recipient that you are looking forward to their reply. Keep it very short, one short sentence only.\n\n* signature - Sender's signature. Only include a very basic farewell-line like \"Thanks, Klemen\", \"Best, Klemen\", \"Regards, Klemen\". Do NOT generate full Klemen Hrovat's signature.\n\n--\n\nALSO IMPORTANT:\n\n* Carefully examine the last communication event from the prospect (buyer) and the last communication event from the seller. These two events will give you the most relevant information on how to write your email.\n* Do not repeat information or courtesy sentences from the previous emails that the seller has already sent. For example, if the seller already expressed best new year's wishes in the previous email, do not repeat them in this email.\n* The email content needs to be in the same language as the rest of the communication in the context.\n\n\nThe following is the correspondence between the buyer and the seller. The last event in this list is the latest one. The latest event is probably the most important one for making a decision.\n\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-10 08:26:44.807306."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "subject_line",
          "recipients",
          "greeting",
          "opening_line",
          "body",
          "closing",
          "signature"
        ],
        "properties": {
          "body": {
            "type": "string",
            "title": "Body"
          },
          "closing": {
            "type": "string",
            "title": "Closing"
          },
          "greeting": {
            "type": "string",
            "title": "Greeting"
          },
          "signature": {
            "type": "string",
            "title": "Signature"
          },
          "recipients": {
            "type": "array",
            "items": {
              "type": "string"
            },
            "title": "Recipients"
          },
          "opening_line": {
            "type": "string",
            "title": "Opening line"
          },
          "subject_line": {
            "type": "string",
            "title": "Subject line"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "msg_01Pw2oTtMVcY5dKp6fSTvyGv",
  "model": "claude-3-sonnet-20240229",
  "usage": {
    "total_tokens": 2508,
    "prompt_tokens": 2001,
    "completion_tokens": 507
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"subject_line\": \"Re: Calendly: Intro to Meetings.bio\", \"recipients\": \"Kendall Walker\", \"greeting\": \"Hi Kendall,\", \"opening_line\": \"Thanks for providing the background information before our call.\", \"body\": \"I understand that as a preclinical CRO based in France, Porsolt offers a wide range of in vitro, ex vivo, and in vivo services for safety and efficacy studies across various therapeutic areas. Your client base includes mid and large pharma companies as well as small/mid biotech firms globally, and in the US market, you are particularly known for your CNS capabilities.\\n\\nHowever, your current outreach strategy to completely new leads in the US market is not yielding the desired conversion rates. This is where Meetings.bio comes in - we specialize in helping companies like yours generate high-quality meetings with decision-makers at target accounts. \\n\\nOur approach involves leveraging our extensive database of verified contacts, coupled with personalized multi-channel outreach campaigns tailored to your ideal customer profile. We work closely with your team to understand your value proposition, target accounts, and buyer personas, enabling us to craft compelling messaging that resonates with your prospects.\\n\\nFurthermore, our Account-Based Marketing (ABM) strategies ensure that your message is delivered to the right stakeholders within each target account, increasing the likelihood of meaningful conversations and advancing opportunities through the sales pipeline.\\n\\nDuring our call, I'd be happy to discuss in more detail how Meetings.bio can help Porsolt amplify its outreach efforts in the US market, increase visibility across your therapeutic portfolios, and ultimately drive more qualified pipeline for your sales team.\", \"closing\": \"I look forward to our conversation and exploring how we can collaborate to achieve your growth objectives.\", \"signature\": \"Best, Klemen\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712737618
}

{
  "events": [
    {
      "id": 1639,
      "body": "<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>",
      "type": "meeting",
      "title": "Calendly: Intro to Meetings.bio",
      "sender": null,
      "persons": [
        {
          "emails": [
            "kwalker@porsolt.com"
          ],
          "full_name": "Kendall Walker",
          "last_name": "Walker",
          "first_name": "Kendall",
          "organizations": []
        }
      ],
      "direction": "EventDirection.BIDIRECTIONAL",
      "timestamp": "2024-02-22T22:15:00Z",
      "message_id": null,
      "recipients": null,
      "cc_recipients": null,
      "bcc_recipients": null
    }
  ],
  "offering": null,
  "deal_name": "PORSOLT",
  "prospects": [
    {
      "emails": [
        "kwalker@porsolt.com"
      ],
      "full_name": "Kendall Walker",
      "last_name": "Walker",
      "first_name": "Kendall",
      "organizations": [
        {
          "name": "PORSOLT",
          "domains": [
            "porsolt.com"
          ],
          "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
          "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
        }
      ]
    }
  ],
  "deal_owner_email": "klemen@meetings.bio",
  "primary_prospect": {
    "emails": [
      "kwalker@porsolt.com"
    ],
    "full_name": "Kendall Walker",
    "last_name": "Walker",
    "first_name": "Kendall",
    "organizations": [
      {
        "name": "PORSOLT",
        "domains": [
          "porsolt.com"
        ],
        "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
        "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
      }
    ]
  },
  "deal_owner_full_name": "Klemen Hrovat",
  "deal_owner_last_name": "Hrovat",
  "deal_owner_first_name": "Klemen",
  "deal_owner_customer_name": "Meetings.bio",
  "deal_owner_customer_domain": "meetings.bio",
  "primary_prospect_organization": {
    "name": "PORSOLT",
    "domains": [
      "porsolt.com"
    ],
    "industry": "MECHANICAL_OR_INDUSTRIAL_ENGINEERING",
    "description": "Porsolt is an internationally recognized Global CRO (Contract Research Organization) that provides drug discovery, screening, efficacy, and safety services. With over 35 years of experience, Porsolt offers tailored solutions for discovering treatments ..."
  }
}

{
  "id": 32033,
  "deal": {
    "id": 560,
    "name": "PORSOLT",
    "owner": 2,
    "stage": 4,
    "public_id": "5cf0b743-4b50-4463-9103-a3755838c986",
    "external_id": "17656118199",
    "last_modified_in_crm": null
  },
  "vars": {
    "pipeline_stage": "EXPLORATORY",
    "pipeline_stage_binary": [
      "EXPLORATORY",
      "PROPOSAL"
    ]
  },
  "state": "CREATE_TASK_FOR_EMAIL_RESPONSE",
  "status": "IN_PROGRESS",
  "next_task": 1030,
  "events_hash": "bd5f9613eb2b86326a727cc7128859be33783afb",
  "fingerprint": {
    "events": "bd5f9613eb2b86326a727cc7128859be33783afb",
    "offering": "2ef87dc4b9c9e813e0e0433d7547e6b7541d95f5",
    "prospect": "13d1d0befdfe27f64dcf8703ce7bc272ff215882",
    "deal_owner": "ec6bf4d5effdd54ce2a619ab6b933981f503e715"
  },
  "next_task_key": null
}

{
  "model": "gpt-4-0125-preview",
  "messages": [
    {
      "role": "system",
      "content": "The user will provide text that you need to parse into a structured form.\nTo validate your response, you must call the `format_response` function.\nUse the provided text and context to extract, deduce, or infer\nany parameters needed by `format_response`, including any missing data.\n\nAlso note that: You are a professional sales email writer. Your task is to respond (reply) to the last buyer's email. This email will be sent by the seller Klemen Hrovat from Meetings.bio. Be mindful of the fact that the buyer has most likely sent the last email with a clear information goal. The email needs to have the following components:\n\n* subject_line - Email subject line. Short and to the point.\n\n* recipients - List of recipients of this email. Be careful to only include the recipients (or one single recipient) with which you were communicating in the last email exchanges. Do not add other recipients if not explicitly requested or required.\n\n* greeting - Salutation. Greets the recipients of this email. It is important to inspect the past conversation and address the recipients in a similar manner when it comes to the register. Consider only short greetings like \"Hi (recipient's first name),\" or \"Dear Dr. (recipient's surname),\" depending on the chosen register.\n\n* opening_line - The opening line of the email. It should be a continuation of the greeting and should be a short sentence that leads to the body of the email. The opening line should be between 10 and 20 words.\n\n\n* body - The body of the email. To write the body, follow these rules:\n  - Needs to address the buyer's questions or concerns.\n  - Be mindful of the fact that the buyer has most likely sent the last email with a clear information goal. The buyer's intent might be (but is not limited to) one of the following: postpone the discussion to a later time in the future; acquire more information about the product or services; acquire information about pricing; understand how to proceed (next steps); something else.\n  - Whenever possible, talk about time in relative terms (last week, yesterday, two days ago...) rather than absolute. \n  - Do **NOT** start the body with \"I hope this email finds you well\", \"We haven't had a chance to connect\", \"I haven't heard from you\", \"touching base\", \"just checking in\", \"wanted to circle back\", and similar email openings as they provide no value to the recipient. Simply start with the main message, do not include any uninformative opening sentence. \n  - Do not start the first sentence with \"Following our last conversation\" or a something similar. Simply omit this part and go straight to the point.\n  - Do not include any opening or closing statements in the body. Limit the body only to informative and to the point content. \n  - Mimic the register from the past conversation. \n  - Do not repeat information or courtesy sentences from the previous emails. \n  - The length of the body should be between 100 and 250 words. If formulating a response to the buyer's enquiry requires more words, it is acceptable to go over this limit. \n  - Go straight to the point without too much fluff, but keep it kind and polite.\n\n* closing - A courtesy closing statement. Tell the recipient that you are looking forward to their reply. Keep it very short, one short sentence only.\n\n* signature - Sender's signature. Only include a very basic farewell-line like \"Thanks, Klemen\", \"Best, Klemen\", \"Regards, Klemen\". Do NOT generate full Klemen Hrovat's signature.\n\n--\n\nALSO IMPORTANT:\n\n* Carefully examine the last communication event from the prospect (buyer) and the last communication event from the seller. These two events will give you the most relevant information on how to write your email.\n* Do not repeat information or courtesy sentences from the previous emails that the seller has already sent. For example, if the seller already expressed best new year's wishes in the previous email, do not repeat them in this email.\n* The email content needs to be in the same language as the rest of the communication in the context.\n\n\nThe following is the correspondence between the buyer and the seller. The last event in this list is the latest one. The latest event is probably the most important one for making a decision.\n\n\n\nYou have been provided the following context to perform your task:\n    - The current time is 2024-04-10 08:35:42.621992."
    },
    {
      "role": "user",
      "content": "The text to parse:\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nTo avoid any doubt, this is the LAST EVENT:\n\nEVENT TYPE: meeting (Bidirectional)\nSUBJECT: Calendly: Intro to Meetings.bio\nSENDERS: None\nTIME: 2024-02-22 22:15:00+00:00\n\nBODY:\n\n<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>\n\n-- END OF MESSAGE --\n\n-=-\n\nADDITIONAL CONTEXT:\n\nDEAL NAME: PORSOLT\nOFFERING: None\nDEAL OWNER: Klemen Hrovat\nDEAL OWNER EMAIL: klemen@meetings.bio\nDEAL OWNER COMPANY: Meetings.bio\nPROSPECT NAME: Kendall Walker\nPROSPECT COMPANY: PORSOLT"
    }
  ],
  "functions": [
    {
      "name": "format_response",
      "parameters": {
        "type": "object",
        "required": [
          "subject_line",
          "recipients",
          "greeting",
          "opening_line",
          "body",
          "closing",
          "signature"
        ],
        "properties": {
          "body": {
            "type": "string",
            "title": "Body"
          },
          "closing": {
            "type": "string",
            "title": "Closing"
          },
          "greeting": {
            "type": "string",
            "title": "Greeting"
          },
          "signature": {
            "type": "string",
            "title": "Signature"
          },
          "recipients": {
            "type": "array",
            "items": {
              "type": "string"
            },
            "title": "Recipients"
          },
          "opening_line": {
            "type": "string",
            "title": "Opening line"
          },
          "subject_line": {
            "type": "string",
            "title": "Subject line"
          }
        }
      }
    }
  ],
  "max_tokens": 1500,
  "temperature": 0.0,
  "function_call": {
    "name": "format_response"
  },
  "request_timeout": 600
}

The text to parse:
EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

To avoid any doubt, this is the LAST EVENT:

EVENT TYPE: meeting (Bidirectional)
SUBJECT: Calendly: Intro to Meetings.bio
SENDERS: None
TIME: 2024-02-22 22:15:00+00:00

BODY:

<strong>Location: </strong>https://us06web.zoom.us/j/89033232193?pwd=v10zoWNMFceJJZybwPKm0u9iTZmcpi.1</br></br><strong>Contact's Time Zone: </strong>Pacific Time - US & Canada</br></br><strong>Please share anything that will help prepare for our meeting.</strong></br>Porsolt is a pre-clinical CRO based in France, we offer in vitro, ex vivo and in vivo safety and efficacy services across a broad range of therapeutic areas. Our client base is both mid and large pharma as well as small/mid biotech globally and in the US. In the US we are best known for our CNS capabilities, and we are trying to increase our increase our visibility and traction across other therapeutic portfolio's. Our current outreach strategy to completely cold leads  in the US is lacking conversion.</br></br>

-- END OF MESSAGE --

-=-

ADDITIONAL CONTEXT:

DEAL NAME: PORSOLT
OFFERING: None
DEAL OWNER: Klemen Hrovat
DEAL OWNER EMAIL: klemen@meetings.bio
DEAL OWNER COMPANY: Meetings.bio
PROSPECT NAME: Kendall Walker
PROSPECT COMPANY: PORSOLT

{
  "id": "msg_01Pzvbz4o8MVfPMvN3emsrVk",
  "model": "claude-3-sonnet-20240229",
  "usage": {
    "total_tokens": 2476,
    "prompt_tokens": 2001,
    "completion_tokens": 475
  },
  "object": "chat.completion",
  "choices": [
    {
      "index": 0,
      "message": {
        "role": "assistant",
        "content": null,
        "function_call": {
          "name": "format_response",
          "arguments": "{\"subject_line\": \"Improving outreach strategy for US market\", \"recipients\": \"Kendall Walker\", \"greeting\": \"Hi Kendall,\", \"opening_line\": \"Thank you for providing the background information about Porsolt and your goals.\", \"body\": \"I appreciate you sharing details about Porsolt's services, client base, and the challenges you're facing with lead conversion in the US market. With our experience working with life sciences companies, we understand the importance of an effective outreach strategy tailored to your target audience.\\n\\nAt Meetings.bio, we specialize in helping companies like yours improve their sales engagement and drive better results. Our platform leverages data-driven insights and personalized outreach to connect you with the right decision-makers at pharmaceutical and biotech companies across the US.\\n\\nWe can work together to identify the key decision-makers and influencers within your target accounts, and craft targeted messaging that resonates with their specific needs and pain points. Our multi-channel outreach approach ensures your value proposition reaches the right people at the right time, increasing your chances of starting meaningful conversations.\\n\\nAdditionally, our platform provides detailed analytics and reporting, allowing you to track engagement metrics and continuously optimize your outreach efforts for maximum impact.\\n\\nI believe our expertise in the life sciences industry, combined with our data-driven approach, can help Porsolt significantly improve its outreach efforts and drive higher lead conversion rates in the US market.\", \"closing\": \"I look forward to discussing this further and exploring how we can support Porsolt's growth objectives.\", \"signature\": \"Best, Klemen\"}"
        }
      },
      "logprobs": null,
      "finish_reason": "stop"
    }
  ],
  "created": 1712738155
}